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GHAFfER 1 
INTRODUCTION
%  personal interest in thyroid piiysiology,. initially aroused
by Professor E.M. McGirr during my undergraduate tenure of a
Carnegie research scholarship, was later fostered by the opportunity
of working with Drs* J.A. Thomson and W.R# Greig in the University
Department of Medicine, Glasgow Royal Infirmary. The work reported
in this thesis was performed while I was in turn a registrar, then a
lecturer in medicine and finally an honorary senior registrar*
At that time, in vivo studies with radioactive iodine had
provided a firm basis for the scientific evaluation of tliyroid
function for two decades* Currently, the development and widespread
application of radloimmunologioal techniques has quietly revolutionized
the routine investigation of patients with suspected thyroid disease
and in particular, in vitro measurements of serum thyroxine,
triiodothyronine and thyrotrophin provide indices of thyroid function
which are both highly discriminating and more convenient to patient
and clinician* Although the adoption of specific hormone assays
heralds autumn for the routine evaluation of thyroid status with
radioactive iodine, the in vivo approach is necessary when information
on the thyroid metabolism of inorganic iodide is required* Such data
may be relevant to both diagnosis of thyroid disease and assessment^ 
^ f  anti-thyroid treatment effectiveness*
Paralleling advances in radioimmunology, the increasing
of radionuclide imaging devices will now permit an
\
accurate aaalyais of rapid changes in thyroid radioactivity with 
time (kinetic analysis). This thesis has explored the use of in 
vivo kinetic analysis with a directional counting system and by 
Investigating thyroidal iodide transport and organification, has 
attempted to predict areas of diagnostic and therapeutic potential 
for future development.
The experimental section of the thesis opens by defining the 
important physical problems in measurement of thyroid radioactivity 
and continues with an account of the development and assessment of 
a directional counting system designed specifically to provide 
accurate quantitative information on rapidly changing radioactivity 
in thyroid. The random and systematic errors associated with the 
use of this technique are subsequently studied in detail.
The next section of the thesis has as its theme, the assessment 
of thyroidal iodide transport using technetium as pertechnetate*
Studies using diffusible autoradiography clearly confirm the similar 
handling of pertechnetate and iodide by the thyroid transport mechanism 
and justify the application of a conventional thyroid mathematical 
model to pertechnetate kinetics in thyroid* Human in vivo experiments 
which consolidate and expand existing knowledge of thyroid physiology 
of pertechnetate are described thereby permitting a critical 
assessment of the value of pertechnetate for clinical investigation* 
Experiments which explore one potential application of pertechnetate 
in the treatment of human thyroid disease, namely its use to predict 
the adequacy of radioactive iodine therapy for thyrotoxicosis are 
also described.
The thesis then goes on to expand the kinetic theory of radio­
active iodide organification in thyroid. From this basis, a 
sensitive clinical test for detecting inorganic iodide in thyroid 
is developed, namely the intravenous perchlorate test* Combining 
in vivo human studies with rat experiments, evidence which argues 
that thyroidal iodide transport is rate-limiting for thyroid hormone 
synthesis in human but not in rat thyroid is presented. An extension 
to the mathematical treatment of iodide organification in thyroid 
permits presentation of a theoretical analysis for calculating the 
organification rate of inorganic radioactive iodide in thyroid.
Knowledge of the effect of thyroid disease on iodide organification 
is obtained in depth using the intravenous perchlorate test. The 
procedure is shown to be a useful adjunct to measurement of serum 
anti-thyroid antibodies for the diagnosis of Hashimoto’s disease and, 
in addition, a large proportion of patients with simple goitre are 
clearly shown to have an imexplained defect of iodide organification 
in thyroid. Investigation of thyroidal iodide organification 
following treatment of thyrotoxicosis with radioactive iodine-131 
or 125 provides clear evidence that iodine-125 is more effective 
for selectively inhibiting function at the apex of tliyroid follicular 
cells. This finding confirms current views on the raicrodoeiraetry of 
each radionuclide in thyroid.
Finally, an unusual case report of reversible, inherited 
hypothyroidism is presented.
The role of kinetic analysis in the investigation and therapeutics
- B
of human thyroid disease has not been fully defined but the present 
work indicates the scope for such studies and establishes areas for 
future development.
PLAN OF THESIS 
The thesis is presented in one volume. Appendix 1 contains 
supporting tablesj appendix 2 contains an account of standard methods; 
appendix 3 contains detailed mathematical derivations. References 
are presented at the end of the thesis.
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OF THE THYItOlD GLAND » A REVIEW
Historical Introduction
Goitre was recognised by man before the Christian era (Rolleston, 
1936) and its empirical treatment with seaweed or burnt sponge 
documented from as early as the twelfth century (Matinovic and 
Eamalingaswami,, 1958)* Following the report by Davy in I8I5 that 
seaweed was rich in iodine, Goindet (I824), a doctor in Geneva, first 
suggested a relationship between goitre and iodine end attempted iodide 
supplementation in his goitrous patients* The resulting violent 
opposition to iodine therapy from his medical colleagues soon forced 
him to abandon this experiment* Despite the subsequent demonstration 
by Ghatin (I852) of iodine deficiency in soil and water of endemic 
goitre areas, it was four decades before Bruns (1894) and Reinhold 
(I894) reaffirmed the usefulness of iodide supplementation in treatment 
of goitre* In 1895* Bauman conclusively demonstrated a high 
concentration of iodine in thyroid and Oswald (l899)e o chemist from 
Zurich, later confirmed a high iodine concentration in thyroglobulinA 
Isolation of thyroxine by Kendall (1915) and elucidation of its 
chemical structure by Harrington (1926, 1927)» firmly established thq^  
role of iodine in thyroid metabolism but further major advance ytus 
impeded by inherent limitations in the chemical method*
Following the epoch-making discovery of radioactive iodine by
i1
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Figure 11 The follicular arrangement of normal human thyroid.
Fermi in 1954? it was soon appreciated (Hamilton, 1938) that radio­
active forms of iodine were oheraioally indistinguishable from the 
stable form and that observation of the metabolism of this measurable 
radioactive label would illuminate the intricate pathways of body and 
thyroidal iodine* Publication of the original studies of thyroid 
function with (Hertz et al, 1938) and (Hamilton and Soley,
1939) was followed by a prolonged period of research into the 
structure and function of the tÎQToid and its hormones. The back­
ground knowledge on fundamental aspects of tliyroid function which has 
accrued since then is collated in the remainder of this chapter*
The thyroid gland consists of two lobes lying laterally against 
the trachea and connected by the isthmus anterior to the second and 
third tracheal rings* Its average weight in the non-goitrous adult 
is 20 g* The morphological unit is the follicle, made up of a single 
layer of epithelium surrounding a mass of homogeneous colloid 
comprised mainly of thyroglotaulln (Figure l). The follicles appear 
isolated from each other (isler et al, I968) and, though the mean 
follicular diameter is 3OO w. (Means et al, 1963)9 considerable 
heterogeneity in both follicle mid follicular cell size has been 
clearly demonstrated (Wollman, I965)*
Electron microscopy has revealed the ultrastruoture of thyroid 
follicular cells (Heimann, I966) and confirmed the presence of an 
uninterrupted follicular basement membrane and microvilli at the 
apical cell surface projecting into colloid*
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Figure 2: The cycle of iodide metabolism.
Dietary iodide is absorbed from the upper gastrointestinal tract 
and circulates in plasma as free inorganic iodide (Figure 2) (Myant 
et al, 1950)" Some plasma iodide is excreted by the kidney (McConaliey
et al, 1951)• The remainder is accumulated by thyroid, oxidised, then
bound to tyrosine by displacement of hydrogen from the 3 position of 
tyrosyl residues in peptide linkage in thyroglobulin with foxmiation 
of mono and di-iodotyrosine (Tong, 1971 )<• Thyroxine and triiodotliyronine, 
foamied by coupling of iodotyrosine molecules (Johnson and Tewksbury,
1942)» are subsequently split from linkage with thyroglobulin by 
enzymatic proteolysis (McQuillon et al, I96I) and released into plasma 
as active hormones* Following hormonal de-iodination in body tissues, 
released iodide is re-cycled back into the plasma iodide pool (Pitt- 
Riversÿ I967)*
The Iodide Transport Mechanism 
Iodide forms only 5 % 10"'^5'o of igneous rock and there is a similar 
concentration iai normal soil (Moeller, 1952)* Human and animal thyroid 
has shown a remarkable adaptation to this environmental scarcity by 
developing an efficient iodide concentrating mechanism* Labelled 
hormone can be demonstrated in functioning thyroid only seconds after 
exposure to radioa-ctive iodide (De Groot and Davis, I96I)* This 
concentrating mechanism can be conveniently divided.into iodide 
transport and iodide organification by the chemical dissociation 
achieved using a thiocarbamide drug (for example, carbimazole)* This
drug prevents organification of accumulated iodide but al-lows iodide 
transport to continue (Sohaclmer et al, 1944)*
Site of Iodide Transport
Aatwood (1944) and Vander3.a,an and Yanderlaan (1947) noted that
under chemical iiihihitlon of iodide organification, the thyroid
concentrated radioactive iodlde-ljl fh*om plasma* Pitt-Rivex’S
and Trotter (1953) demonstrated that under similar conditions,
thyroidal iodide transport resulted in concentration of inorganic 
3 31I inside the follicular lumen. Doniach and Logothetopoulos
(1955b) and Y/olff and Maurey (1963) showed that intact thyroid cell
membrane was a prerequisite for iodide concentration, and suggested
that the active transport meohatiism was placed at the apical margin
of the cell. Subsequent observation (Tong et al, I962) of iodide
concentration by isolated thyroid cells, which presumably had neither
apical nor basal regions, later tended to confirm the general impression
that basal membrane was the primary site of iodide transport in vivo*
Further evidence for this has been obtained from the reports of
Williams and Vickery (1965) and Andros and V/ollman (1967)5 who both
localised in follicular cells of mice at short time intervals
after radionuclide administration and clearly demonstrated transfer 
3 3lof cellular I to the follicular lumen at later intervals*
The position has been partial3y clarified by observations of 
Woodbtny and Woodbury (I963)* Using a micro-electrode technique, 
they found the interior of tliyroid follicular" cells to be 50 millivolts 
negative to both perifollicular tissue and follicular lumen* This 
potential difference makes an active transport mechanism for iodide 
mandatozy and implies subsequent iodide diffusion down the electro-
10
Chemical gradient into follicular lumen and colloid. The report by
Wolff (1964) that iodide transport is sensitive to external K***
concentration would certainly corroborate the electrochemical theory.
This electrochemical *model' provides an explanation for the
ability of thyroid to maintain a concentration of inorganic iodide
in the follicular lumen, twenty times higher than plasma in normal
subjects and several hundred times higher in thyrotoxicosis (Beraon
and Yalow, 1955)*, V/hen iodide organification is blocked, the
151magnitude of thyroidal accumulation of I is essentially the 
resultant of influx and efflux. Evidence indicates that influx
is effected by the iodide transport mechanism while efflux depends on 
iodide back-diffusion against the electrochemical gradient. In 
addition to their blocking effect on iodide transport (Wyngaarden 
et al, 1953 )f perchlorate and thiooyanate modify this back-dif fusion 
from the follicle (Scranton et al, I969) possibly by an effect on the 
electric potential of cell membrane mediated by loss (vfolff et al, 
1968; Young et al, 1970)#
There is now abundant evidence that iodide released from intra- 
thyroidal de-iodination of iodotyroslnes forms a biochemically 
distinct and functionally separate thyroidal iodide pool from iodide 
transported into the gland from plasma (Nagataki and Ingbar, 1963; 
Simon, I963). At the present time, the role of this * second pool* 
iodide is largely unknown.
Mechanism of Iodide Transport
Freinkel and Ingbar (1955) end Slingerland (1955) confirmed that
11
thyroidal iodide transport was an active process and not simple 
diffusion by demonstrating its dependence on oxidative phosphorylation* 
Wyngaarden et al (1953) observed saturation kinetics with iodide and 
competitive inhibition by thiooyanate, perchlorate and other monovalent 
anions* The iodide transport mechanism also accumulates bromine (Yagi 
et al, 1953), astatine (shellabarger et al, 1954) and other members of 
periodic group 7, namely rhonium, manganese, and technetium, all as 
the pero3{yanion (Baumann et al, 1956)* Anbar et al (1959) believe 
that the existence of thyroid trmisport for these varied anions is 
determined mainly by their physical properties (i.e. size, shape and 
charge) rather than by their chemical nature or periodic relationship* 
Pertechnetate in particular has a molecular volume and configuration 
similar to the heavy iodide atom (Wolff, 1964)* It seems plausible 
therefore that a single specific membrane site is involved in transport 
of all accumulated anions*
Control of Iodide Transport
Haliai et al (1963) have conclusively shown that thyrotrophin is 
the most important regulator of tliyroidal iodide transport* The 
report (Wilson et al, 1968) that thyrotrophin stimulation of iodide 
transport could be blocked by inhibitors of protein synthesis such as 
Aotinoniycin D, and that ITmax (the velocity of reaction with fixed 
enzyme concentration but high substrate concentration) of the transport 
mechanism was increased without altering Km (the substrate concentration 
required to yield half the maximum velocity), suggests that thyrotrophin 
acts by inducing an enzyme or enzymes which augment the capacity of the
12
transport mechanism for iodide.
In Vivo Assessment of Thyroidal Iodide Transport
The most preoise index of tliyroid transport of iodide is the
tliyroid unidirectional clearance of a rate-constant proportional
151to the ;number of I atoms transported into the gland per minute
(Rail et al, I964). The standard thyroid clearance of Keating et al
(1949) and lisant et al (1949b), however, itieasures the net result of
influx (transport) and efflux (baok-diffusion). It is an
accurate approximation of the unidirectional clearance because iodide
transport in most subjects appears to be the rate limiting factor in
151hormone synthesis# There is consequently little inorganic I in
normal thyroid available for diffusion (Rail, 1956)# Vdien inorganic
is present in the gland (e#g# pharmacologic block to iodide
organification), diffusion reduces the accuracy of net clearance
measurements for assessing the transport function. Unidirectional 
151clearance of I is mandatory in this situation and its measurement 
involves use of kinetic analysis (Beraon and Yalow, 1955)*
Larsson (1955) first recognised that the simply measux'éd 15 - 20 
minute uptake of thyroid was little affected by the presence or 
absence of a pharmacologic block to iodide organification and was 
therefore an index of thyroidal iodide transport# Using this test 
he demonstrated excellent discrimination between euthyroid and 
thyrotoxic subjects. Following confirmation of these findings by 
Vanderlaan (1957) and Higgins (1959), Thomas (196O) suggested that 
the 15 minute uptake of thyroid should allow assessment of thyroid
13
function during antitliyroid drug therapy for thyrotoxicosis.
Alexander (1969) used this test successfully to measure thyroid
suppressibility in thyrotoxic patients on oarbimazole therapy*
The concepts of thyroid clearance and early uptake will be
enlarged upon in later chapters*
Clinical Defects of Thyroidal Iodide Transport
A defect of thyroidal iodide transport is the rarest inboim
error of thyroidal iodine metabolism. First described by Federman
(1958), only tlirse additional cases have since been studied in
detail (Stanbury and Chapman, 1960; Gilboa, I963)* Criteria for
151diagnosis include a low thyroidal I uptake with a low salivary-
151plasma and gastric juice-plasma I ratios.
The Iodide Organification Mechanism of Thyroid 
A recent change of emphasis in thyroid research away from iodine 
metabolism and towards a more biochemical approach to hormone 
synthesis has thrown new light on many aspects of thyroidal iodide 
organification.
Site of Iodide Organification
The precise site of iodide organification remains an enigma 
though it is now accepted that tjm^ osyl residues bound on peptide 
linkage to thyroglobulin are iodinated, rather than free tyrosine 
which is later incorporated into thyroglobulin (Alexander, 1964; 
Gartouzou et al, 1964; Seed and Goldberg, 196$; Soodak et al, 1964)* 
Citing evidence from thyroid autoradiographic studies, Leblond and 
Gross (1948) championed the view that thyroglobulin is formed and 
iodinated in thyroid follicular cells and subsequently extruded into
14
the follicular lumen, This view was challenged hy Hadler (1954)
who demonstrated slow formation of tliyroglohulin but rapid appearance 
3 51of organified I 3ja colloid. His suggestion that iodination 
occurred pr^ jnarily :m colloid in association with microvilli was in 
accordance with the findings of.Stein and Gross (1964). The recent 
demonstration by Taurog (1970) of a peroxidase enzyme in association 
with the apical Cell membrane coupled with a complete absence of 
iodlnating enzymes in the soluble portion of tliyroid constituents 
inoludïjig thyroglobulin (be Groot, I962), argues for the cell membrane 
as site of iodination* Since isolated thyroid cells have been shown 
to iodinate external protein (Paston, 1961)9 the indications are that 
follicular cells synthesize and secrete tîiyrogiobulin into the 
follicular cell lumen where iodination occurs while the molecule is 
in contact with the apical cell membran.e (Hadler, 1965)*
Mechanism of Iodide Organification
Horton (1943) first demonstrated formation of iodotyroslnes in 
vitro using a preparation of tliyroid slices* Subsequent Investigators 
have preferred thyroid-cell particle preparations and have shown that 
iodination is inliibited by propylthiouracil, thiooynate and anoxia, 
though perchlorate and thyrotrophin were without effect (Taurog et 
al, 1955)* The presence of an iodide peroxidase enzyme was confirmed 
by Serif and Kirkwood (1958) and Alexander (1959)# This enzyme has 
since been isolated and puz’lfied by Taurog (1978) who observed its 
inhibition by excess iodide in the medimi, possibly explaining the 
Wolff-Ghaikoff effect (1948)# Taurog also confirmed that antithyroid
15 -
drugs reduce iodination by inhibiting the peroxidase enzyme system
and localised the enzyme on apical cell membrane, a site first
suggested by Benabdeylil et al (1967)*. Fav/cett and ICirlcwood (l954)
postulated the existence of a tyrosine-iodiJiase to catalyse
incorporation of iodine into tyrosyl residues of thyroglobulin, but
further evidence for its existence has not been forthcoming.
Assessment of Iodide Organification In Vivo
Though still the subject of vigorous debate, most evidence is
against iodide organification being a major rate-liming factor in
tliyroid hormone synthesis (berson and Yalow, 1955; Vanderlaan, 1954)#
151Consequently, the detection of inorganic I in thyroid indicates a
defect of iodide organification*
Stsmley and Astwood (1947) first demonstrated discharge of 
151inorganic I from glands of thiouracil-trea/bed patients given
thiooyanate and later showed perchlorate to be more potent (Stanbury
and Wyngaarden, 1952)* Subsequent reports of the inhibitoiy effect
of thiooyanate, on thyroidal iodide organification in vitro (Uiranlslin
et 8,1, 1944» Alexander, 1959» Paston, I965) and in vivo (Eaben,
1949; Wollman, ,1962b) have highlighted perchlorate as the most
suitable discharging agent. Most workers failed to find evidence
for inlilbition of iodide organification by perchlorate (Halmi, I960;
Richards and Ingbar^ 1959» Do Groot and Buhler, 1971) though Greer
(1966) elegantly demonstrated gradual inhibition of iodide organification
with increasing concentrations of perchlorate in his system*
Morgans and Trotter (1957) introduced an oral perchlorate
3 51discharge test and demonstrated inorganic tliyroidal I in Hashimoto*s
16
disease, indicating defective iodide organification in this condition* 
Since then, intensive study has confirmed the usefulness of this type 
of test though lack of sensitivity makes detection of small amounts
1 XI
of inorganic I in thyroid difficult* This insensitivity is 
reflected in variable dosages of perchlorate, timing of its 
administration, and variable criteria for interpretation of the test, 
found among its protagonists (Fraser et al, 196O5 Floyd et al, I96O; 
Basohieri et al, 1963; Stewart and tkirray, I966). The clinical 
value of this perchlorate test can be enhanced by combining the oral 
dose of ^^^1 with carrier iodide (Takeuchi et al, 1970; Susuki and 
Mashimo, 1972)*
131The organification rate of accumulated thyroidal I can also
be used to indicate functional integrity of iodide orgwiification in
thyroid. Using complicated kinetic analysis, Berson and Yalow (1955)
131failed to demonstrate inorganic thyroidal I in hyperthyroid 
subjects and concluded that the organification rate was near unity* 
Ingbar (1955)# using similar techniques, believed that free iodide 
was present in normal glands and computed a binding rate of 0*91 per 
hour in euthyroid subjects (i*e* binding of 91fo of trapped iodide per 
hour)* Since these investigators leaned heavily on both kinetic 
analysis and major assumptions, and since the presence or absence of 
free thyroidal iodide cannot easily be verified by chemical separation 
procedures, these reports are difficult to evaluate* Robertson et al 
(1971) have recently used a digital computer to calculate the iodide 
organification rate in vivo but these workers assumed the presence of 
unorganified thyroidal iodide in their analysis.
- 17
It has been reported (Owen et al, 196O) that the thyroidal
uptake pattern found in major defects of iodide organification is one
of rapid uptake followed by rapid fall due to diffusion of inorganic
radionuclide from the thyroid. This feature is not shown when the
defect is partial (Gray, 1973) and has little practical application,
Olinical Defects of Iodide Organification
Lerman (1946) described two hypothyroid goitrous brothers with 
131a high thyroidal  ^I uptake and low tliyroid content of inorganic
iodine, Stanbury and Hedge (1958) later reported thiooyanate 
l31
dischargeable  ^I in thyroid glands of three goitrous cretins and 
introduced the concept of thyroid dyshormonogenesis by suggesting 
that these observations were compatible with a congenital defect of 
iodide organification# Similar findings vmre confirmed in other 
liypotlijrroid (Stanbury,, 1951# Schultz et al# 1957# Gardiner et al# 
1959; McGirr et al# 1959) and euthyroid ( Olay ton et al# 1958) 
goitrous patients# Recently peroxidase enzyme deficiency has been 
confirmed in vitro, (Valenta et al# 1971? Hagen ©t al# 197&) in 
cases of familial goitre with a clinical defect of iodide 
organification*
Morgans and Trotter (1958) added to the spectrdm of familial
goitre with impaired utilisation of trapped iodide# when they found 
131inorganic I in the thyroid of patients with goitre-deafness 
syndrome, first described by fendred (1896), Pendred*s syndrome is 
a recessive hereditary disease (Brain# 1927; Fraser# I964# 1965) 
and though in its complete form# it is characterised by congenital 
deaftiiitism# goitre and a defect in thyroidal organification of
18
iodidef atypical forma occur (Baz, 1966) with goitre abaent (Yon 
Harnack et al, I961), or only alight auditory disturhanee (Kcaaer, 
1961). It is of intereat that outliyroid patients with goitre and 
a partial defect of tlyroidal■iodide organification have Been shown 
to laok peroxidase enayme (Hagen et al, 1971) while one patient with 
classical P@ndred*s syndrome has recently Been reported to have 
normal peroxidase activity (Zyimggren and Yecohio, 19&9). Thxo 
latter patient may have a different, and as yet unknown, iodinating 
defect.
Acquired disorders of iodide organification may he observed in 
the course of thyroiditis (Morgans and Trotter, 1957)» following 
radioactive iodine therapy (Kirkland, 1954)» or after drug 
admiaistration. Such drugs include thionamides (Stanley and 
Astwood, 1947)» thiooyanate (Barker, 1956), para-aminosalicylic acid 
(Kumrower, 19511 lîacGrregor and Somner, 1954)» reaorcinol (Bull and 
Eraser, 1950; Bouiaoh and Eraser, 1950) and iodide in high dosage 
(Paris et al, 196O). Susceptibility to iodide inhibition is 
sometimes familial (Oroughs et al, 19&5) and is often acquired in 
patients treated with radioactive iodine to ameliorate hyper­
thyroidism (Braverman et al, 1969).
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CMB?ER 2 - smemiY
The human and animal thyroid gland has effectively compensated 
for the environmental scarcity of iodide by developing an efficient 
ionic transport mechanism to extract iodide from plasma. This 
mechanism, active in nature, is stimulated by thyrotrophin (under 
normal physiological conditions) but it is not specific for iodide 
since other ions, including pertechnetate and perchlorate, may also 
be accumulated. Iodide transport can be shown to be biochemically 
distinct from iodide organification, the next step in hormone 
synthesis.
Following transport into thyroid follicular cells, iodide Is 
rapidly oxidised by peroxidase and organified to tyrosyl residues 
in colloidal thyroglobulin. This organification reaction is 
specific for iodide and probably occurs when the ion traverses the 
apical cell membrane. There is no unanimity on whether iodide 
transport or organification provides the rate-limiting factor for 
hormone synthesis. Discharge of accumulated inorganic thyroidal 
following oral perchlorate administration currently provides 
the only reliable clinical index of defective iodide organification.
99m0-142 Mev.
9 8 6 %
0-140 Mev.
98-6% >2 (internal 
conversion ratio=0 095 )
990-0
2®R u (stable)
opeciTic uamma-ray constant 
=  0 SGR-cm^mC hr. at 1cm.
Average Local Energy Deposition 
= 0-014Mev. per Disintegration
'T'l = 0  002 Mev. 
■^2 =0*140 Mev. 
'^2 = 0 14 2  Mev.
Figure Js Decay scheme and nuclear properties of techneoium«99»rt
" (from Smith, 1964).
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DEVELOH#m! Off KHOTODGE OF mBOHNETim
Since technetiim (atomic weight 45) was first observed in 
stellar spectra (Harper et al, 1962j îtason, I966) tv;enty-*one 
radionuclides and metastable states of the element have been man- 
made by nuclear bombardment or nuclear fission* In 1939» Seaborg 
and Seagre reported the discovery of teohnetium-99ra# metastable 
state of technetium-99 * This radionuclide, as the peroxyanion
pertechnetate, has subsequently proved of immense practical value 
as a biological tracer in clinical nuclear medicine.
Génération. Physical GharacteristicB and Dosimetry of 
Teohnetium-99m
Technetium-99^ Is obtained as the daughter product of 
molybdenum-99 (^%o) which is in turn recovered as a fission product 
or produced by neutron bombardment of ^^ÆOé It is conveniently 
produced carrier-free as pertechnetate (^^^c) in isotonic saline 
from a generator (half-life 67 hours). Figure 5 gives the 
decay system and nuclear properties of ^ ^^04 It has a short 
physical half-life of 6 hours and decays by isomeric transition 
emitting a 140-Kev gamma ray without primary particulate radiation* 
The effective Eg due to conversion electrons (0^ of the 140-Kev 
gamma)* low energy gamma and fluorescent photons, is 0*014 Mev.
The specific gamma ray constant (î'ÿ) is 0*56 E/mc hour at 1 cm.
^^^c generated in the oxidised state as pertechnetate behaves
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biologically like iodide, wliile in the reduced state (Eckelman et 
al, 1971) it is readily tagged to various organic compounds (Anders, 
I960),
Assuming no excretion, dose calculations give 320 m rad/mo to 
stomach and 10 m rad total body irradiation ?/hen the radionuclide is 
given intravenously (Smith, 1965)* ^^Tc arising from decay
gives trivial radiation exposure because of the minute amount formed 
(imC ^^^c decays to 3.3 % 10 ^  mGi^%c) and its long half-life 
(2 X 10^ years)*
Distribution of Perteclmetate
Harper et al (1962) demonstrated a similarity in body 
distribution of pertechnetate and inorganic iodide. Confirmation 
and extension of these studies by Sorenson and Arohambault (1963) 
and Andros (1965) revealed selective concentration of pertechnetate 
by sallvaiy glands, stomach and thyroid, but exclusion from CBF,
In contrast to the predominant urinaiy excretion of iodide (Skansa, 
1948), Andros reported that only of administered perteclmetate 
■was recovered from urine in 24 hours while its cumulative fa.eoal 
excretion at J2 hours was 20 •? 3C^ , Using whole body counting to 
measure (60 day half-life) and (4*3 day half-life),
Beasley et al (1966) confirmed more precisely an initial rapid 
urinary excretion of perteclmetate and subsequent slower faecal 
excretion. Bio-transformation of pertechnetate to other chemical 
forms in liver with subsequent biliary excretion (Abdel-Wahab et 
al, 1967) is a plausible explanation for the pattern of faecal 
excretion.
- 22
Thyroid Physlolo^w of Pea^ teohiietate
Teelmetium is a member of group VII A of the periodic table.
As pertechnetate, it is actively concentrated by the tliyroid along 
with other members of the VII TH group namely iodide, bromide, 
astatide and perrhenate (Wolff, I964)* Wolff (1962) assumed that 
tliyroid transport of these anions was ensyme catalysed and found that 
the T/S (pertechnetate) was greater than T/s (iodide) in sheep thyroid
slides when anion concentrations v/ers adjusted to the Km ( t / s  being
the ratio of anion uptake per g thyroid to plasma anion concentration 
per ml)# He calculated Km values (half-saturation) of 3-5 x 10"^m 
for perteclmetate and 3 % 10*"^ m for iodide* Wolff (19&3) further 
demonstrated that, like iodide transport, perteclmetate transport 
required cellular integrity, metabolic energy and K"*', and in addition, 
that pertechnetate, iodide and perchlorate could each inhibit thyroid 
transport of the other two anions with a potency determined by the 
individual Km value* He concluded that pertechnetate and perchlorate 
were competitive inhibitors of iodide transport and that these ions 
share with iodide, the same transport mechanism* As previously 
described, their kinship appears due to a basic similarity in 
molecular size, shape and charge (Wolff, I964)*
While it is accepted that iodide is the only halide which under­
goes further metabolism in thyroid, there is debate about binding of 
pertechnetate to thyroid tissue* In well conceived studies on 
patients (Andros et al, 1965J Shimmins et al, 1969b) and rats (Heck 
et al, 1968), no binding of pertechnetate to thyroid protein was
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detected. Other in vitro studies using rat tliyroid (Sooolow and 
Inghar, I967# Papadoupolos et al, 1967) and in vivo clrlnlcal 
studies (Burke et al, 1972) have reported the presence of minimal 
pertechnetate binding* Using chromâtograpliy, Abel«¥ahab et al 
(1967) have detected small emounts of pertechnetate labelled 
iodotyrosines in urine. Clearly, the weight of evidence suggests 
that a small though variable portion of transported pertechnetate 
does undergo chemical combination with a thyroid protein*
The thyroid unidirectional clearance of pertechnetate is 
approximately half the iodide unidirectional clearance in vitro 
(Andros, 197i) despite the lower perteclmetate lün (Vide supra).
This is possibly due to plasma protein bindilng of the carrier-free 
perteclmetate used in these studies (Wolff and Maurey, 1962; 
Oldendorf et al, 1969î Hays and Green, 1971) thereby reducing 
the availability of plasma pertechnetate to the tliyroid transport 
mechanism.
Hole of Pertechnetate in Thyroid Hivestigcaiion
In the last decade, 1ms become one of the most widely
used radionuclides in clinical nuclear medicine* Its physical 
GÎmxaoteristics which epitomise the ideal radioactive tracer 
(Herbert et al, I965) include a low gemmia energy permitting easy 
collimation without excessive tissue absorption, minimal B emission, 
short half-life allowing daily tests, and its carrier-free 
availability* A comparison between the physical properties of 
radionuclides used in investigation of tliyroid disorders is shorm
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TABIiB 2
RADIATION DOSE TO ADULT THYROID (Rada/// Ci) FROM 
RADIONUCLimS USED FOR THYROID INVESTIGATION
1520 % 10"^
17 % lO”^
1120 X 10“*^
16 X 10"^ 
0.2 X 10“^
From Goolden et al, 1968
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in Table 1* The radiation exposure to the thyroid from each 
radionuclide is shov/n in Table 2*
A 15 - 20 minute thyx’oid uptalœ of has been measured
using directional scintillation counting (Andros et al, 1965?
Van't Hoff et al, 1972), quantitative scintiscanning (Andros et 
al, 19655 Shimmins et al, 1968b; Atkins and Richards,, 1968; Do 
Garrotta et al, I968) and scintillation camera teoMiques (Hurley 
et al, 19725 Burke et al, 1972). The range of ^ ^^Tc uptalce 
reported for subjects with normal thyroid function was 0.5 « 
administered dose,, while in patients with thyrotoxicosis it was 
5 - 40?b dose* In subjects with simple goitre the range was 
1 - 5^ dose, and in patients with primary hypothyroidism, less 
than Ifo dose* Hauser (I97l) noted that the uptake in Hashimoto*s 
disease tended to be higher than normal with a range of 1 8^  ^dose*
Altiiough the diagnostic information obtained feom measurement of 
uptakes is readily available from equivalent radioactive 
iodine uptalce parameters (McGill et al, 197i5 Gray et àl, 1973)# 
use of does confer some distinct advantages to both clinician
and patient# Firstly, the low radiation exposure to tliyroid from 
allows less hazardous tliyroid studies on children (Bodds and 
Powel# 1967) and pregnant vjomen. Secondly, as kinetics are
uninfluenced by concurrent administration of drugs which block 
thyroidal iodide organification, the ^^^0 uptalce can be used as an 
index of hyperthyroid disease activity in patients talcing antithyroid 
medication (Goolden et al, 1973*) and can also indicate thyroid
%
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suppressibility (Shhmlna et al, 1971; Goolden et al, 1971)»
Using quantitative sointiscaniiing, Shimmins et al (1968b) 
measured tliyroid unidirectional clearance of and found a mean
clearance in liyperthyroid patients of 287 ml/min compared to 37 ml/ 
min in normal subjects* Lack of confirmâtory data in the 
literature reflects the complexity of the kinetic analysis required 
for this measurement*
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Although perteolmetate-^^^o has an ♦ iodide-lllce*
distribution in body tissues with concentration in thyi'oid, salivary 
glands, gastric mucosa and choroid plexus, its binding to plasma 
proteins and predominant faecal excretion are in direct contrast to 
iodide pliyslolo^. ^^^c shares the tliyroidal iodide transport 
mechanism with perchlorate and other ions because they are similar 
to iodide in molecular size and shape. Organification of tliyroidal 
to tyrosyl residues in follicular colloid does not occur to any 
major extent. While tlyroid uptalce studies with ^^^c provide the 
same fundamental information as early uptake studies with 
advantages of ^^\’c include a low radiation exposure to patient and 
attendant personnel and a facility for measurement during antithyroid 
drug therapy.
SMMTIQN OF OHITRQIDAL IODIDE IB5TABQLIS1
Ihen Borelli (1608-1679)» Professor of Mathematics at Pisa, 
used his knowledge of mechanics to simulate the human skeletal 
system, he initiated a technology which has stimulated the 
imagination of successive generations of medical scientists and 
hioengineers (henihan, 1972)* A recent expansion in hospital 
computer services has generated renewed interest in mathematical 
simulation and its applications to the field of medicine (Pack and 
Murray-Sraith, 1973)*
Introduction of radioactivity increased the scope of biological 
simulation (Robertson, 1957) und studies of tracer behaviour in 
living organisms (kinetic analysis) has allowed a dynamic portrayal 
of complex metabolic events, unobtainable within the confines of more 
conventional disciplines such as biochemistiy.
Gompartmental Analysis in Radioactive Tracer. Studies
For mathematical purposes, constituents of living systems must 
be regarded as being located in distinguishable plmses or volumes of 
homogeneous composition which are delineated physically or chemically 
but not necessarily anatomically (Sheppard and Householder| 1951)* 
These are designated pools or compartments * The rate-constant of 
transfer of a substance from one compartment to another is that 
fraction of the compartment which enters another in unit time (i.e. 
the clearance of one compartment into another)* A biological model
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is oonstruoted by defining the compartments and routes of transfer 
between compartments (Stanbury and Brovmell, 1954)» In radioactive 
tracer studies, models are fortunately represented mathematically by 
simple linear differential equations*
Basic assumptions critical to this type of analysis have been 
outlined by I%tthews (l97l)» These include firstly an assumption 
that there is uniform distribution of substance in each compartment 
at all times with instantaneous and homogeneous mixing of tracer with 
tracee. Secondly, that behaviour of the tracer is identical to that 
of tracee in the compartment. Despite the doubtful validity of the 
first assumption, model theory (Brownell et al, i960) and practice 
have played a valuable role in clinical medicine, notably in the 
tliyroid arena (Brovmell, 1951» Beimian, 1968; Be Groot et al, 1971a; 
Alexander et al, 1971) but also in other fields (l#A.E.A*, 1971)*
La common with other advancing technologies, oompartoiental 
analysis will be seen to be a phase in the development of radionuclide 
kinetic analysis, A second phase has possibly already begun with 
the concept of occupancy (Orr and Gillespie, I968),
Mathematical Models of Thyroidal Iodide Transport 
and Organification
Although the precise mechanisms of iodide transport and 
ox’ganlfication are unimown, mathematical models have been devised 
which agree well with experiiiiental data (wolff, 1964)# Useful 
Information has been obtained in man (Berson and Yalow, 1955) and in 
animals (tollman, 19545 Wolliaan and Heed, 1959» Wollman and Reed,
TWO COMPARTMENT THYROID MODEL .
T
f  C Ktp 1
THYROID
p
PLASMA
POOL
Figure ki Tvjo-compartmeut thyroid model where T is the fraction 
of administered radionuclide or ) in the
thyroid pool, P fraction/Litre is the plasma concen­
tration of radionuclide, G Litres/min is the thyroidal 
unidirectional clearance and IC min"^ the thyroid 
exit-rate constant of radionuclide•
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1962a) using kinetic analysis of the equilibration curves of blood
and thyroidal radioactive iodine* It must be stressed, hov/ever,.
that with major assumptions involved, rate-constant values obtained
represent informed approximation rather than scientific accuracy
(Bei’Ê^er, 1962)* Model analysis has been performed graphically
(Shimmins et al, 1968b), by analogue (Brovmell, 1951» Hickey and
Brownell, 1954» Beilinson and Rotblat, 1955) and by digital
computation (Robertson et al, 1971)•
Two Oomnartment Thyroid Model
Vihen organification of iodide in thyroid is blocked with a
thiocarbamide drug, radioactive iodide (^^^l) concentration by
151thyroid is the resultant of two processes, nmnely I transport to
7,"
tliyroid from plasma and %  diffusion from thyroid to plasma. A 
similar concept is appropriate for pertechnetate which is unbound in 
thyroid tissue.
In a two compartment model (Figure 4)» the thyroid is considered
to be a structureless compartment containing a uniform concentration
*T* of Exchange of plasma at concentration *P* with
151thyroidal I is oiioracterised by the linear differential equation.
« O.P. - K^p. T.
15‘1 / \ 'Ti^oid unidirectional clearance of ' ^1 (G) equals ? x F where
l51V is thyroid plasma, flow and F is the fraction of plasma ' I 
transferred from plasma to thyroid* Thyroid exit rate-constant,
•J Z]
is the fraction of thyroidal “ 'I transferred to plasma in 
unit time.
THREE COMPARTMENT THYROID MODEL.
THYROID
PLASMA
ORGANIFIED IODIDE POOL
I #
UNORGANIFIED IODIDE POOL
Figure 5; Three-compartment thyroid model where T is the
fraction of administered I in the thyroidal
inorganic iodide pool, P fraction/Lltre is the
plasma concentration of inorganic C Litres/
rain is the thyroidal unidirectional clearance
(of K min"'^  the exit-rate constant and
min*^ the organification-rate constant of
] 31the thyroidal inorganic ' I pool.
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Wollman and Reed (1959) have shovm mathematically that the 
shape of thyroid equilibration curves is determined by the time 
dependence of plasma I concentration and by the exit rate-constant*
?oi
When iodide organification is permitted, simu^^tion is possible
by adding an organic iodine compartment to the basic two compartment
model (Figure 5)* In this model, the thyroid is considered to be
two structureless oompax’tments, one containing a uniform concentration 
151'T* of inorganic I, the other a uniform concentration 'B* of
151 151organified ■ * I, Plasma I at concentration P is transferred to
the thyroidal inorganic compartment at a rate equal to the
content of 0 litres of plasraa/min* Of tliyroidal (t ), a constant
fraction equal to *1^ *^ is incorporated into the bound compartment
each minute * A second fraction, K^p diffuses from thyroid to plasma
each minute* The complete process is characterised by the linear
differential equation*
dT/at = CP -
It must be assumed that compartmental concentrations of stable
151iodide are constant and that no organified I la metabolized during 
the period of study*
Workers using the three compartment model have predicted inorganic 
in normal human tliyroid glands (Xngbar, 1955) and in animals 
("Wollman and Heed, 1962a), while others feel that there is insufficient 
evidence for this prediction in humans (Berson and Yalow, 1955)* As 
each study leans heavily on either kinetic analysis with its inherent
51
131assumptions, or chemical separation of inorganic I from excised
thyroid, tissue, it is currently accepted (Rail et al, I9645 De
Greet, 1965) that until fresh evidence is available, the presence of 
human
inorganic iodide in/tliyroid under normal binding conditions must
remain sub judice# Despite limitations imposed by ignorance of
thyroidal iodide pools, the author found the concept of a three
compartment model useful and particularly suited to measux'enent of 
] %]
the ’I organification rate
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SEGTIOI 2
TEOmiOAL ASPECTS OF THYROIDAIi KIMIC STUDIES
IN VIVO
Chapter 5 The extrathyroidal neok radioaotivity
Chapter 6 Arterio-venous differences a systematic error
of thyroid clear'anc© measurement
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TES EKTRATHYROIML NEOK RADIOAGTIVITÏ
This chapter describes the development and assessment of a 
special collimator, designed to reduce the contribution of extra- 
thyroidal neck radioactivity to total neok counts during thyroid 
uptake measurements.
SmODUQTIQN
It is difficult to measure with precision the quantity of 
radionuclide (usually ^^^1 or in tliyroid* Although
allowance for scattered radiation can be made using a tliyroid 
pliantom to approximate in vivo conditions, systematic errors due to 
variation in position and anatomy of the gland cannot be entirely 
eliminated*
In addition to thyroid radioactivity, a counter placed over the 
neck will detect radionuclide present in plasma, extracellular 
fluid and salivary glands. This extrathyroidal activity (s*T*A*) 
is usually 3 “ of administered dose when the I*A*E*A* 
collimator is used (Hilditch et al, 1967» Andros et al# 1965)*
Since a normal thyroid uptake of or 20 minutes after
injection is only 1 - 4^ of administered dose, uncertainty in 
estimating the correction for other neck radioactivity leads to 
unaoceptably large errors in the derived thyroid uptake (Shimmins 
et al, 1968a).
Various methods have been proposed for the indirect estimation
\
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of E*T,A. with preoision in thyroid uptake measurement the prime 
objective* Some authors îiave determined B.T.A. by counting over 
the neok with a thick lead shield covering the thyroid (Floyd et 
al, i9605 Alexander et al, 1962) while others have used the 
counting rate over the thigh (%ant et al, 1949&; Goolden and 
Mallard, 1958? Fraser et al, i960)* In contrast, various workers 
calculated B*T.A* by making assumptions regarding its variation 
with time. Berson et al (1952) assumed that B.T.A, was a constant 
fraction of not trapped by the thyroid or excreted by the
kidney, while Veall and Vetter (1958) and Koutras and Sfontouris
(1966) assumed that B,T*A* changed in proportion to the plasma
radioactivity* Oddie et al (1955)» made no assumptions and found
151that when E*T*A* was expressed as a fraction of I radioactivity 
remaining in the body and not In the thyroid, it was not constant 
but did not fall as rapidly as plasma radioactivity* He recommended 
the routine use of a mean value of B.T4A* obtained in a group of 
patients using standard neck counting geometry* Hilditch et al
(1967) recently confirmed Oddie*s findings using quantitative 
sointiscanning techniques to selectively measure the contribution 
of E*T*A* to total neck radioactivity* In similar?studies Shimmins 
et al have formulated equations for calculating the early thyroid 
uptake of (1968a) and ^^ \^pc (1971)# These equations also 
depend on the mean value of B.T*A* obtained in a group of patients*
Since a high absolute value of E.T.A* is inappropriate for 
precise thyroid kinetic analysis, the author reduced the volume of
— Crystal
Original
Collimator
13 2cm
3mm outer cylinder 
2 mm cylinder
19*5cm
Trumpet
cm
6i Diagram of speolal oolliraation showing original 
eollimator and addition in long a;xis.
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neck 'seen* hjr the counter by constmotlng a simple collimator which 
still inolitded the whole of thyroid in its field. ®ie physical 
characteristics of this collimator were evaluated and acoura,oy of 
F.f.A# measurement was assessed*
MgERIALS AID IMOHOD3
(a) Collimation
The collimator was used with a directional scintillation counter 
(l.D.L, type 6630)* Review of $00 routine rectilinear tliyroid 
scintiscans taken over the preoeding twelve months with a Selo scanner 
showed that 94^ of all tliyroid images could he included in a 7*5 % 
cm rectangle* The atm of collimator design was therefore to view
an area of maximum response of at least 7^5 % 7*5 cm* The final
system (Figure 6) consisted of a sodium iodide crystal detector (if" 
diameter x 1" thick) mounted within the original diverging collimator 
which extended 3§" heyend the surface of the crystal where it 
presented a diameter circular viewing area* To this collimator 
was added an axial cylinder of 2 moi lead with internal diasieter
5*5 dm and extent 15*2 cm beyond the crystal* A trumpet of 2 mm
lead^ added to the end of the cylinder# was of rectangular cross-* 
section ( 9 x 6  cm) at its outer edge hut tapered to fit the cylinder 
at the other end* Overall length of additional material was 18#8 cm 
(19*5 OBOi from the crystal) and the Intended collimator to skin 
distance was 2 cm* Finally# a second lead cylinder 5 mm thick was 
placed around the first*
(h) Collimator Oharaoterietics
The collimator response and field of vie?/ were measured using
131j
100
10cmcmIO
Figure 7s Visual field of special collimator for point 
sources of and in air moved along
the long axis at distances of 25#5 cm (1), 
23*5 cm (2) and 21*5 cm (5) from the crystal.
131 J
100
cmIO 10 cm
Figure 8: Visual field of special collimator for point
sources of and ^^\’c in air moved along
the short axis at distances of 25*5 cm (1), 
23.5 cm (2) and 21.3 cm (3) from the crystal.
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small soiîToes of (360 ke?) and (14O ke?) both for long
and short axis of the trumpet at distances of 21*5? 23.5 and 25.5 
cm from the crystal*
(c) Fxtrathvroidal Radioactivity Study
]3*Q?,A. of and were measured following their separate
and simultaneous intravenous injection (25 and 4OO uGi respectively) 
in noHDal subjects whose tîiyroid uptake had been completely blocked 
with oral potassium perchlorate* A ratemeter and potsntiometric 
recorder v/ere used for each radionuclide giving a continuous recording 
of ,A* Eadionuelide standards in a thyroid phantom were used for 
system calibration#
Random Errors
1) §i^iiutioal_^Tr^’iation^in^outgut^voltage of^rate^tor
Error for was approximately 1^ and for less
than l^ è
2) Repositioning of patients
«U M  M  If *■•■ «> «H H> W  W M  A  M  W * t  W t *  Mt •aiillO
With a reproducibility of collimator « neck distance of 
± 0*5 om? both and had an error of approximately
5fo*
3) Injection calibration
«i w  «!««•<■• ni K» wt iH ^  i w  an «»
Standards had an approximate error of 3^b*
REStJlffiS.
(a) Collimator Characteristics 5?he collimator response curves 
in the long (Figure 7) and short axis (Figure 8) were virtually 
identical for both and Although not ideal in
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sîiarpnees of eut off at greatest distances from the central 
axis, the collimator gave a 90fô response within a maximum 
area of 8 % 7*5 om at a working distance of 25*5 om from the 
crystal.
in (Cable 3* Each E.Ï.Â* value given is the mean of three
o f
measurements at intervals of 24 hours on eaeh/five patients, 
a total of fifteen measurements.
It can be seen that
1) B.T.A* is approximately 1 * 2^ of administered dose for
both and
2) There is a close correlation between the EiT.A* of
and when measured simultanéously#
3) The difference between the E*T#A* at 5 and 20 minutes is 
small (iiO# approximately an 8^ fall)*
The error {± 2 S#D* ) for E*f *A* measurement in a single subject was 
approximately 10^ for and 20^ for
DI80Ü88I0K
131In previous thyroid ^ % uptake and olearanoe studies using 
directional counting^ measurement precision was precluded both by 
the high absolute value of E**T*Ai and by errors inherent in its 
indirect estimiation# Early attempts to measure tliyroid uptake of 
^^^0 with similar systems were likewise abandoned because of the 
E*T*A* problem (Andros et al# 1965)& Though technological advance 
in the form of quantitative scintiscanning (Hilditoh et al# 1967)
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and scintillation camera technique8 (Hurley et al, 1972) have obviated 
this particular source of error, the expense and teolmioal knowledge 
requl3?ed for those studies limits the facility to major centres*
With the closer collimation described, the author reduced E.T.A* 
to 3C^ of the value obtained with an I*A,S*A* collimator* FuTthemiore, 
as individual measurements of E*T*A, were acceptably reproducible, the 
error in early tl^ rroid uptake measurement was greatly reduced from 
approximately 40^ to IC^L It is interooting that E*T*A* of both 
radionuclides Is similar because, despite identical collimator fields 
for and the lower energy gamma ray of is more
easily absorbed in neck tissues. This finding might indicate tliat 
most of E,T*A* is anteriorly placed and not uniformly distributed.
The prescribed reduction in collimator field does impose a 
restriction on the size of goitre for which accurate measurements 
are possible. The author has found that an 8 x 7*5 om rectangle 
{$Qfo response) is adequate to cover all but veiy large thyroids.
In only 6fo of 300 routine thyroid scintiscans was tl'^ roid greater in 
sl0O timn this and the majority of these were largo non*toxio goitres 
of ^  100 g.
This collimator has been used for all subsequent in vivo human 
studies reported jja this thesis.
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SWÆÆARY - o m p i m  5
A olosely collimated scintillation detector was constructed 
specifically to reduce the contribution made by extrathyroidal 
radioactivity to total neck radioactivity during measurements of 
the uptake of and ^^^c by the thyroid. The error of these 
measurements was thereby reduced A?om 4^  to 1(^L The restricted 
field of the collimator was found to be adequate for uptake 
measurements in all thyroid glands under 100 g in weight.
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GHAPTm 6
AEmiO*.VENOïïS DIFPERM^GE t A 8Y8TEMATIG EREOE 
OF THYROID OmARAHOB MEASIïRmm
This chapter describes the detection of a significant difference 
between arterial and venous plasma concentrations of radioactive 
iodine and perteohnetate^^^^c at short time intervals after their 
intravenous injection. The resulting systematic error in measurement 
of thyroidal radioactive iodine olearanoe had not been previously 
recognised, A study of measures designed to reduce this error is 
also reported.
INTRODUCTION
The thyroid clearance of radioactive iodide*!)! after
intravenous injection is lmo\m to be higher in the first few minutes
after administration than at later times (Sohulta and Sieve# 1957?
Koutras and 8fontouris# 1966; Yamamoto et al# 1969). Explaining
this phenomenon, Hall and 00-authors (I964) described normal thyroid
in terms of aai open three-compartment model and distinguished between
^unidirectional ’ and *net* clearance rates# The * unidirectional*
131clearance corresponds to the initial flux of I ions from plasma
to the hypothetical iodide pool in thyroid while *net* clearance
131
represents a balance between I ions entering and leaving the 
thyroidal iodide pool at later times#
Though Hall’s explanation is plausible, the author’s failure to 
detect free intrathyroidal iodide in normal and tliyrotoxic subjects
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(Gray et al, 1973) was Incompatible with this theory. It seemed
appropriate therefore to investigate possible sources of systematic
error which could liave resulted in an apparent fall 5ji thyroid
clearance of I at early intervals after injection. Two possible
sources of error were studied. Firstly, a slow diffusion of plasma
inko red cells could progressively reduce plasma
concentration in venous blood samples awaiting radioactivity counting,
Confirmation (Gray et al# 1973) of the rapid equilibration between
l31
plasma and red coll I first described by îîyaîit et al (1930)
excluded this possibility. A second possible source of error was
slow mixing of injected between arterial and venous plasma pools
131
which, with venous sampling, would result in underestimation of ^ I
concentration in arterial plasma perfusing thyroid. Accordiaigly, a
l31study was made of the arterio-venous difference of I and 
perteclmetate-^^^o (^^^o) iïi euthyroid and tl%rrotoxic patients 
following radionuclide injection. In addition, the precision of 
praecordial radioactivity counting for paralleling arterial plasma 
radioactivity was studied as an alternative to ax'terial plasma 
sampling.
MATJ3RIALS AWB W H OBS 
Six male patients were studied initially and all gave their 
consent after careful explanation of the procedure. Four patients 
were eutliyroid and had a 4 inch teflon arterial catheter in the (ll) 
brachial artery for respiratory Investigation, None was in 
respiratory failure. Two untreated tiiyrotoxic patients each had a
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(r ) brachial aiterial catheter Inserted by an experienced operator.
Following an intravenous injection of 2) uCi and 4OO uGi ^^^0
to each subject in the (r ) arm, simultaneous arterial and venous
blood samples vrare talten at intervals from 1 to 20 minutes following
radionuclide administration. Venous samples were taken from a small
venous cannula in the (l ) arm. Plasma samples (2 ml) were counted
for and ^^\’c in a well-type scintilla^tion counter,
3 31The thyroid uptaice curve of I was followed nil the two
thyrotoxic patients by a directional counting and recording system
previously described (Chapter 5), Extrathyroidal radioactivity of 
3 31I was subsequently measured in each patient by repeating the 
13125 uCi 1 dose 5 minutes after an intravenous injection of 100 mg
sodium perchlorate. Increased radioactivity in the system was
considered extratliyroidal and subtraction froBi the initial thyroid
131uptalce curve allowed quantitation of the rate of I uptake by thyroid* 
In a further 4 euthyroid patients, arterial and venous plasma 
radioactivities were measured following a )0 second intravenous 
infusion of 4OO uCi In addition, however, the praecordial
radioactivity curve was monitored by a similar counting and recording 
system to that used for thyroid uptake studies. Calibration of the
praecordial count rate was obtained by equating the 20 minute venous
\
and praecordial radioactivities. An infusion technique was used 
since radionuclide injection resulted in a variable praecordial 
count rate in the first minutes after administration, possibly due 
to a bolus effect, \
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of earlier praecordial radioactivity is possible.
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IffiSÏÏLÏS
Decay curves of arterial and venous plasma and
radioactivities in a eutiiyroid subject are shown m  Figure 9#
131 99n?Corresponding I and Tc plasma curves from a thyrotoxic subject 
are shorn in Figure 10» Similar curves were found in all other 
subjects studied. The notable feature is a significant difference 
between arterial and venous concentration of radionuclide in the 
first 6 minutes after injection. Thereafter, arterio^venous
1^1
difference is less pronounced. Although decay rates of plasma I 
and are similar^ there is a persistently higher concentration
of 99^Tc.
131Measurements of thyroid ' I clearance in the two thyrotoxic
patients at intervals following radionuclide injection are shovm in
Table 4* The calculation has been made usùig arterial and venous 
131plasma I radioactivities separately. Use of venous plasma 
samples can be observed to give a falsely high rlnitial clearance value. 
Arterial plasma, venous plasma and praecordial radioactivities 
following a 30 second intravenous InfUsion of ^^^Tc in a representative 
patient are shown in Figure 11* Although the calibrated praecordial 
count rate was consistently more representative of arterial than 
venous radionuclide concentration, it failed to predict accurately 
the arterial curve,
Hi 10 subjects studied with ^^^Tc, arterial plasma concentration 
at 1 minute was 0,28 ^  0,08 fraction dose/litre (îïiean ^  1 S,D,) and 
in 6 subjects studied with ^^^1, arterial plasma concentration at 1
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minute was 0«20 + 0,06 fraction dose/litre (mean + 1 8«D,),
DISCïïSSIOÎT
Thyroid follicular cells are probably exposed to a plasma 
133 99mconcentration of T and To in perifollicular capillaries which 
approximates to that in arterial plasma. It has been assumed by 
previous authors (Schulta and Zieve1957? Rail et al, I964?
Koutras and Sfontouris^ 1966 s Yaaiamoto et al g. I969) that homogenous 
mixing of an intravenous injection of radionuclide occurs within 2 
minutes of administration allowing use of venous plasma samples 
after 2 minutes to approximate the arterial plasma perfusing thyroid* 
The author has shown firstly that this assumption is invalid and 
secondly that the systematic error introduced by using early venous 
plasma smiples could result in the phenomenon of ♦falling tl^ rroldal 
clearance*. Although this data gives little indication of 
the circulatory pliysiology applicable to production of arterio­
venous difference, both slow mixing of arterial and venous plasma in 
the brachial system and diffusion of plasma radionuclide into extra- 
Vascular fluid of the arm are lilcely to be relevant factors.
Precise thyroid clearance, studies in the early phase require 
correction for this error if venous plasma sampling is used, It 
was disappointing that praecordial (ventricular) counting failed to 
provide a suitable alternative to arterial cannulation, This 
probably resulted from variation in the extracardiac contribution 
to total praecordial counts which would occur with time and from 
patient to patient.
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Plgwe 121 Aa?teria.l, venous and simula-bed arterial plasma radio*
activities following an intra;venoua injection of
illustrating partial correction of the venous 
curve for arterio-venous difference.
« -
It is interesting that the plasma concentration of is
higher than that of I and this is probably a reflection of the 
plasma protein binding of (Oldendorf et al, 1970^ Hayes and
Green, 1973)*
To obtain maximum precision in thyroid clearance studies performed 
in the ea^ nly phase with and, ^^^fc and reported in this thesis, 
an approximation of arterial radionuclide concentration was used 
durijig the first 6 minutes after ùijection. To the venous curve of 
each patient, an exponential cun^e was added with a starting value of 
0,3 fraction dose/litre for ^^^c and 0*2 fraction dose/litre for 
which intersected the respective venous curves at 6 minutes 
(Figure 12), The systematic error of arterio^venous difference in 
each patient studied was therefore minimised though not entirely 
elimilnated.
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C M F m  6  "  SHÎÆVIAKY
131A significant arterio-venous difference in plasma I and 
concentration has been noted at early intervals following 
their intravenous injection. It is suggested that the phenomenon 
of falling tliyroid clearance of found when venous samples are
used for clearance calculation, results from this systematic error, 
Praeoordial counting was found to be unsuitable for predicting 
arterial concentration of radionuclide.
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activity of iodide transport as measured by 
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GHAPTER 7
AHTORAdlOGRAPHy OF TE0BHETim!i:*99 
IH RAT THYROID
This chapter describes studies to determine the distribution 
of teolinetium as perteohnetat© in rat thyroid gland*
IHTRODÎTCTION
The uptalce of technetium as pertoolmetate by the thyroid (Chapter 
9) is currently accepted as a useful clinical index of thyroid 
function (Alexander et al, I969) and an acceptable alternative to 
early thyroid uptalce measurements using radioactive iodine (Shinimins 
et al, 1971)* Although Pitt-Rivers and Trotter (1955) have shown 
that radioactive iodide is ooncentrated in follicular colloid ^ the 
intratl'jyroidal site of perteohnetat© concentration has not been 
previously determined.
This chapter reports results of autoradiographic studies with 
pertechnotate-^^To in rat thyroid performed for the author by 
Ito* H* Small, technician in the Department of Oral Pathology, Glasgow 
Dental Hospital*
Autoradiofraohv The principal of tissue autoradiography is simple4 
Thin sections of tissue containing the radionuclide under study are 
placed in contact with a film of photographic emulsion4 Ionisation
in the emulsion induced by radiation results in the formation of 
silver grains in the distribution of radioactivity* Both tissue 
section and emulsion may then be processed so that the relation of 
radioactivity (silver grains) to follicle and cell structure is
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maintained, The main teohnioal problem of autoradiography with 
perteohnetat© relates to the lack of protein binding of radionuclide 
in thyroid since conventional processing of histological sections will 
leach out soluble pertechnetate ions* In this study therefore, a 
freeae*-dxying tecimique was used which prevented movement and loss 
of pertechnetate until exposure to the autoradiographic emulsion was 
completed,
MERL4LS m P  mTHODS
Five Sprague-Dawley albino adult male rats were used* Two rats
received eminotriasole (0,15^ ) in drinking water for three weeks before
99the study; two other rats were fed a normal diet* Pertechnetate- Tc 
(300 uOi) was. administered intraperitoneally to each animal and after 
one hour, one animal in each group received 10 mg sodium perchlorate 
by the same route* Ninety minutes after radionuclide administration 
and under ether anaesthesia, the thyroid end trachea were rapidly 
removed together, fbcosen in isopentansj cooled in liquid nitrogen to 
about -170®C, and sectioned (8 urn) on a cryostat in the darkroom 
without thav/ing* The frozen sections were placed directly on to 
slides previously covered with photographic emulsion (Rogers and 
Brown-Grantj 1971) and were exposed at -30°G for five days in a light­
tight box# The emulsion was developed in D*19B (Kodak Ltd*)^ and 
fixed. Finally the preparations were stained by haematoxylin and 
eosln for examination under light microscopy* The procedure was 
repeated in one other rat given aminotriazole, though the sections 
wore allowed to thaw before preparing autoradiographs.
99Figurv 13 i Autoradiographic raetotion of To primarily over the
colloid of a nozn&l rat thyroid follicle (x $00).
I /
6
Figure 141 Rat thyroid Btlaulated by blocking iodide
99,organification. Autoradiographic reaction of To 
over the colloid with little reaction over enlarged 
follicular cells.
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RjïiSTJLTS,
The follicular axTangement of the thyroid con he recognized on 
histological oxamiuatiou of both uuatimulated (Figure 1$) and 
stimulated glands (Figure I4)* Autoradiographe from those animals 
not given perchlorate disclosed that the major site of perteclmetate 
concentration was the colloid* There was little radioactivity over 
follicular cells or interstitiuïi. In animals given perchlorate, no 
significant radioactivity was seen in colloid confirmiiig discharge 
of radionuclide from the thyroid* Sections of gland which were 
allowed to thaw before preparing autoradiographs failed to show 
localisation of perteclmetate as described above* These sections 
showed a diffuse image over the entire gland*
DisomsiON.
The presence, of an autoradlographi0 image over follicular 
colloid in rat thyroid indicates the selective concentration of 
pertechnetate Y/ithin this structure* Pertechnetate discharge from 
colloid by perchlorate, first reported by Harper et al (1962) has 
been confirmed* This resemblance, both to the localisation (Pitt- 
Rivers and Trotter, 1953; Doniaoh and Logothetopoulos, 1955a) and 
perchlorate discharge (stanbuïy and V/yngaarden, 1952) of thyroidal 
radioactive iodide, confims a basic similarity in transport of 
pertechnetate and iodide by the thyroid, first demonstrated by 
Schindler et al (1966) in tliyroid kinetic studies using both \ 
radionuclides* The author considers these findings justify his 
subsequent extension of thyroid model theory from iodide (Y/ollman 
and Reed, 1962a) to technetium as pertechnetate.
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CHAFTEH 6
DBO^ÏNATION OF THE B A m  OF ACOUMUIATION 
AND L08S OF TEOHNia?H3M*^9m AND
FROM HUMAN THYROID (EANDS IN VIVO
This chapter describes a study of pertechuetate#^^^c and 
iodide*^^^! kinetics in thyroid over a 20 minute period following 
intravenous radionuclide injection, The data has been analysed 
graphically, digitally and with an analogue computer,
INTIjQDUGTION
Thyroid metabolism of iodide can be conveniently described in 
terms of a hypothetical two-compartment model if iodide organification 
is blocked and a three-compartment model if iodide organification is 
proceeding (Chapter 4)# Pertechnetate-^ To accumulation in the 
colloid of rat thyroid (Chapter ?) confirms an anatomical similarity 
in compartmental handling of iodide and pertechnetate by thyroid and 
justifies the extension of model theory to thyroid kinetics of 
pertechnetate# Since this radionuclide is virtually unorganified in 
thyroid, a two-compartment model is operative and its successful 
application to data obtained in vivo on the uptalce of pertechnetate- 
by human thyroid has been reported by shimmins et al (1968b),
To obtain further insight into handling of pertechnetate-^^"Vc 
(^^®Vc) by thyroid in normal and diseased patients, the author has 
recorded both thyroidal uptake and venous plasma concentration of 
^ ^ c  over 20 minutes following its intravenous injection in a series
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of nom&l and thyrotoxic patients* From this data, the two kinetic
parameters which describe the model have been calculated for each
subjectI thyroid unidirectional clearance (c*I/ain), corresponding
to the initial flux of ions into thyroid from plasma, and exit
rate^constant (K^p* min ), corresponding to the continuous efflux of
^^*^0 from thyroid to plasma* Kinetic parameters of radioactive
iodide-131 handling by thyroid were measured simultaneously in
each subject; unidirectional clearance (C) and exit rate-constant
(Krpp) for when iodide organification was blocked with oarbimasole
and net clearance of when iodide organification was normal* This
1?S1
net clearance represents the balance between I ions entering and 
leaving thyroid*
Data analysis has been performed in three ways* .
1* By the graphical technique of Bhimmins et al <1968b).
Z* By a modification of the above using a digital computer to
perform a least-squares fit of the data#
3* By analogue computer.
Consisting of an electrical network which can simulate a biological 
model, the analogue computer is subject to minor Intrinsic errors and 
should theoretically permit more accurate evaluation of the rate* 
constants of a model than graphical methods*
The complete data permits a unique comparison between kinetics of 
99b^ q and in thyroid.
MATERIALS AND HBTHOB 
Garrier-free sodium pertechnetate*^^”^ c <^^Tc) and carrier-free
IV
p e r c h l o r a t e
TANGEMT CONVERSION FACTOR 
- 0-954 x5 
400
T.c.F. - o-om TIME ANGLE TAN T A N X T C F ( ^ )
4 47“ 1-072 0 01275
6 37“
8 27“
10 16“
0-754 0-00896
0-510 0-00606
0-287 000342
®^'"Tc S T A N D A R D  = 111^;
“ 0-954 pc/unit
26-8 units
B A C K G R O U N D  ACTIVITY
TIME mins.
QQjU
Diagx’aiamatio analysis of To dose standard and 
thyroid uptake curve of recorded automatically#
In addition, discharge of thyroidal is shown
after Ï? perchlorate injection* The rate of increase 
of thyroidal content, dT/dt, is obtained by
correcting the measured slope of tangent to this 
thyroid uptake curve# Ihe correction factor consists 
of a scaling correction as numerator and administered 
dose (o.g# 400 iiCi) as denominator to give df/dt in 
fract# admin, dose units. The scaling correction is 
the number of uOi in one length of time scale (l minute) 
to adjust for non-linear plot - in this case 0.954 ^ 5*
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ôoâiiim &odia@*131 were used (Hadioohemical Ge»tre, Amereham).
bpteke QÎ and by thyroid and venous plasma concentration
of each radionuclide were recorded in 32 patients; ? normal volunteers 
with no evidence of thyroid disease, 13 patients with untreated 
thyrotoxicosis and 12 thyrotoxic patients currently taking 43 mg 
carbintaaol© daily*
Instrumentation
The modified directional counter (Chapter 3) was connected to 
isotope counting equipment feeding two scaling circuits, each connected 
via a ratemeter to a separate potentiometrio recorder. One circuit 
counted ^^^1 optiinaliy, the other counted ^^***^ 0, Special collimation 
reduced the contribution to total neck counts of extrathyroidal radio­
activity (KTA) to approximately of administered dose for both 
radionuclides (chapter 3)*
The system was calibrated using suitable standards of I and 
in a Incite thyroid phantom* Cross-activity between channels 
was negligible as administered radioactivity was only l/6th of 
^^*^0 radioactivity* Two ml plasma samples were counted in a well- 
type scintillation counter*
Procedure
patients lay on a couch and the special collimator was carefully 
positioned over the thyroid* Following the simultaneous intravenous 
injection of 400 uOi and 23 uOi the curves of thyroidal
plus extrathyroidal radioactivity for each radionuclide were 
continuously recorded for 20 minutes (Figure 13)* Venous blood 
samples, taken at 3, 3$ ?* 10, 13 and 20 minutes after injection,
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allowed measurement of plasma oonoentrations of each radionuclide* . 
Sodium perchlorate (50 mg) wee injected intravenously at 20 minutes 
(for preparation - see Appendix 2) and recording of total neck radio­
activity of ^^^c and was continued* Although perchlorate 
injection resulted in a rapid *wadhout» of thyroidal ^ ^ c  in each 
subject studied, »washout* of thyroidal occurred only in those 
subjects currently on ceirbimaaole. When ^^”^ c ’washout* was complete, 
a further 400 uOi was injected intravenously* Measurement of
the resulting increase in total neck radioactivity over background 
radioactivity during the subsequent 10 minutes allowed approximate 
quantitation of ^^^c ETA with time* When ETA was required for 
analysis, the corresponding value was substituted since the
difference between either ETA measurement at any one time is marginal 
(Chapter 5) using this collimation*
ANALYSIS OF KXHETXC DATA 
The model employed for ^^^Tc data analysis was a two-compartment 
model (Chapter 4). This model was also applied to data when 
iodide organification was blocked with carbimanole.
Analysis was performed in all subjects by graphical and digital 
means but in 10 thyrotoxic patients* analogue computation was used in 
addition.
Graphical analyaia - ^^”tc
In a two-compartment thyroid model relating to ^^ **TC*
T(t) « Total ^^ ®\pc content of thyroid at time ’t*
(fract* admin* dose)*
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P(t) ss ^ ^ ^ 0 plasma concentration at »t*
(fract* dose/lltre)*
G - Thyroid unidirectional clearance of
(litres/mln)*
K^p 3 Fraction of thyroidal diffusing to
plasma/min (min^ )*
The linear differential equation describing net transfer of 
into thyroid is;
dT/dt = O.P(t) - K^p*T(t) 
Divide this equation by P(t)#
d^dt « G -
H t r
Assuming 0 and are constant, equation 2 is the equation of a 
straight line with:
dT/dt w net thyroid clearance of ^ ^ c  at time *ti**
[tj
T(ti) » thyroid/plasma ratio of at time *ti*.
P
The thyroid plasma ratio T(ti), measured when thyroid and plasma pools
P
are in equilibrium, is termed the Ts ratio and is a special case of 
T(ti).
From the thyroid uptake curve of in the representative
thyrotoxic patient D.M’G* (Figure 15) and corresponding plasma 
concentration curve of suitably corrected for arterio-venous
difference (Chapter 5), we can calculate dT/dt for several times *ti* 
after ^^*\c injection (i*e* slope of the tangent to uptake curve),
T(ti) the thyroid uptake, and P(ti) the corresponding plasma concentration
D.MCG.
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Z
g
5 0 2
a s  0-1
TIME â r T P â î /p T /P
4 00128 0-117 0-08 0-160 147
6 00090 0-137 0-072 0-125 191
8 0 0061 0-151 0-066 0-093 2*29
10 0-0034 0-163 0-063 0*054 2*59
2 3 4
t / p  l it r e s
U.D.C =0-27 litres/min 
Ts =  3 5 litres
Figure 16: Straight-line analysis graph plotting dT/dt/P against
T for various times after IV injection. The
P
unidirectional clearance is represented by the net
clearance dï/dt/P at aero time and the îs ratio by T
P
at equilibrium i.e. when the thyroid net clearance of
99raTc is zero.
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of Kinetic rate^coastants were eabsequently calculated from
thlB data as follows*
1* Graphical
Using equation 2 and graphing dîl?/dt/P{ti) against 5?<ti)
F
(Figure 16), we obtain a straight line whose intercepts are 
thyroid Ts ratio and unidirectional clearance (i.e. net clearance 
at aero time). Also from equation 2# since dT/dt/P(ti) is zero 
when thyroid and plasma pools are in equilibrium# we obtain
“ la
2. Digital
A Wang 700 digital calculator was employed to obtain the 
best line fit of data (dT/dt/P against T/P) using a least-squares 
programme. In addition to precise calculation of slope (K^ p) 
and ywintercept of the line (c)$ an estimate of random error for 
each parameter was obtained.
Graphical Analysis
When iodide organification was completely blocked with carbimazole# 
the above methods were used to calculate thyroid unidirectional clearance# 
<Sa and K^p for
When iodide organification was proceeding normally* the net thyroid 
clearance of was measured by dividing the increase in thyroidal 
from 10 - 20 minutes after radionuclide injection by the average 
plasma concentration during this period. The first 10 minutes 
of the thyroid uptake curve of were ignored to minimise the 
systematic error of arterio^venous difference.
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Graphical Analysis calculation of
Following intravenous injection of sodium perchlorate #
discharged from thyroid at a mono*e%ponentlal rate (Figure 15)#
131
Thyroidal I also discharged mono#e%ponentially when iodide 
organification was blocked# The exponential discharge rate K*^p was 
calculated by plotting# on a log-linear scale for each radionuclide# 
the points of difference between observed thyroid radioactivities 
and asymptotes.
Ana3vsis with Analogue Computer
Technology and circuit diagram used are fully described in 
Appendix 2. For each patient studied# the basic procedure was firstly 
to adjust computer plasma radioactivity to fit the observed radioactivity 
curve of ^^^c* Secondly# the computer thyroid curve was superimposed 
on the observed thyroid curve of ^^®Tc uptake by suitable adjustment of 
computer constants C and When a #best-fit* of thyroid curves
was obtainedt the absolute values of 0 and were obtained from the 
computer.
ERRORS
Random Errors
Measurement of or ^ ^ c  kinetic parameters by graphic analysis 
is subject to many random errors. These include statistical variation 
in ratemeter output# errors in counting plasma radioactivity# variable 
neok-collimator distances# inaccurate dose administration and visual 
estimation of both slope of tangent to thyroid uptake curve and straight 
line in graphic analysis. Assuming that behaviour of in thyroid
200
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Figure l?j The correlation between thyroidal unidirectional 
clearance of and the 10 - 20 minute net
clearance of measured simultaneously in 7
euthyroid and 13 thyrotoxic subjects. The 
regression equation was y = 0.38% 0*00$ and
r s 0,98.
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3.0 in accordance with a two -compartment model, the error of 0 and 
calculation given by digital calculation indicates total random 
error (I’KS), The TES (70/^  confidence limits) for 0 was 1) j- 
(mean ISh) for ^^ ^^ Tc in 6 euthyroid and 13 tliyrotoxio patients and 
10 4 4*0^ (mean ISh) for in 9 thyrotoxic patients.. The TlfS
(70/â confidence limits) for in the same patients was 18 + 6fo
(mean ISD) for and 18 ^ &fo (mean ± ISD) for
Systematic Errors
The most important systematic error is arterio-venous difference. 
Appropriate codirection reduces this error from 155?^ to approximately 
(Chapter 6).
BESÜI/.CS
There was an excellent correlation (r = 0*99) between results 
of thyroid kinetic analysis (o and K^p) calculated by graphical and 
graphical/digital methods* The digital results alone are documented 
in this results section since they are mathematically precise and 
include random error quantitation*
A correlation betnveen tliyroid unidirectional clearance (bhO) of 
^^^Tc and net clearance of ^^^1 is shown in Figure I7* The regression 
equation (y « 0*38x -h 0*009) showed ^^^^c UDC to be approximately 
l/3rd the value of net clearance with r = 0*90* The gradient 
mean 4 ISD was 0.38 f 0,016* Results are summarised according to 
thyroid status in Table 5*
A correlation between ïïjûO of both ^^ "\uc and measured in I4
tliyrotoxic patients currently on onrbimasole therapy is not illustrated 
graphically (results in Table A, Appendix l). The regression equation
•  normal iodide organification 
0 iodide organification blocked
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FigncG 18* In this figure, simultaneous measurementb of tiiyroidal 
unidirectional clearance (ïïüO) of both 
in 14 tj^ Qorotoxic patients on carbimazole (open circles) 
are superimposed on the con'elation between tliyroidal 
UDG of and 10 « 20 minute net clearance of
shown in Figure 17 (closed circles)* The combined 
regression equation is y ^ 0*37x -î- 0*011 and r « 0*95*
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Flgiiro 19* Correlation between the thyroid oxit«rate conatants
of ond measiAred in subjects currently
on oarbhmzole# The regression equation was 
y = 1.17% -f- 0.014 with r - 0.79*
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rate constents of thyroidal and ' I
measured in snbjeots currently on carbimaaole*
The regression equation \ms y « 2*56% « 0,01 and 
r « 0,81.
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(y ~ 0.512c k 0.02) again indioatsd that the parameter was
approximately l/5rd the value for r was 0*74 and the gradient
mean + ISD was 0.5I ± 0.082. Since the gradient mean for the group
who were not on oarhimazole (O.58) is within ISD of the gradient mean
for those on oarhimazole (0.5I i; 0.082), it is unlikely that
oarhimazole administration altered the relationship between 
151and I clearanoes. In Figure 18, the results obtained from these
tliyrotoxic patients on oarhimazole are superimposed upon Figure I7.
The regression egua^ tion of combined data was y » 0,57% + 0*011 (where
y = m)C and x = net or imo) with r = 0*95.
In Figure 19» a good correlation is shovm between thyroidal 
99m 151of To and I in 12 thyrotoxic patients* The regression equation
was y - 1,17% f 0*014 (y “ ^^™Tg and x = K^p) with r = 0.79*
In Figure 20, measurements of K'^p of and in the same
patients are also shovm to correlate well, with a regression equation 
of y « 2 * 5 6 x  - 0.01 (y = ^^™Tc and x ^ K»^p) and r - 0.81.
Surprisingly, correlation between ^^^^0 and K*^p and K^p
and K*^p were poor (Tables B and 0 respectively » Appendix l).
Correlation xias disappointing between equivalent values of 
kinetic indices obtained using the analogue computer with those 
obtained from graphical/digital analysis? r = 0.86 for C and 0.80 
for I{^ p measurement (Appendix 1, Tables B and b).
BISOÏÏSSIOh
Measurement of the unidirectional clearance (UDO) of ^^^0 by 
the thyroid in euthyroid and tliyrotoxio patients demonstrates that 
this index of ^^^c influx into thyroid correlates well with, and
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is directly proportional to, both tîiyroid net clearance of when
151iodide organification is normal and ÜDG of I when iodide
organification is completely blocked. This data has three important
implications. Firstly, the results are consistent with an identical
thyroid transport mechanism for each anion as described by Wolff (1965).
Secondly, tliyroid ÏÏDO of appears to be a precise and direct index
of the iodide transport activity of thyroid and will therefore provide
the same quantitative information aiCforded by measurement of either
tîiyroid net clearance (Rail et al, I964) when iodide organification
is normal or TJBO of (Berson and Yalow, 1955)* This accuracy is
confirmed by the good separation obtained between thyrotoxic and
euthyroid individuals studied using a BBO measurement. The
test was valueless for diagnosis of liypotlTyroldism, however, since
data cannot be analysed if TJBG is ,01 L/raan. Clearly, measurement
of thyroid ÏÏBC of ^^^0 would appear most appropriate for assessment
the
of iodide transport when/efficienoy of iodide organification is in
99mdoubt. Thirdly, since oarbimaaole therapy has no effect on To
kinetics (Schindler et al, I966) the similar proportionality factor
between ^^^c UBO and both UI)0 and net clearance measurements,
151argues that ‘ I tTDO and net clearance rates are similas? when iodide
151organification is normal. Thus, the initial flux of ‘ I ions into 
thyroid would appear equivalent to the resultant of influx and efflux 
at later times. This result, possible only if there is little
unorganified in normal thyroid, implies an iodide organification
rate near unity in the pa,tients studied and confirms pioneer work of 
Berson and Yalow (1955)*
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The author's data conflicts directly with a current theory on
thyroidal iodide metabolism in which an unorganified thyroidal iodide
pool is postulated (Robertson et al, 1971I Shimmina, 1970? Alexander
et al, 1971)" This liypothesis requires ^^^1 UDC to be substantially
larger than net clearance* Since it has been previously shown
(chapter 6) that the initial high thyroid clearance of which is
observed in practice results from a systematic error of arterio-venous
difference, the available evidence argues against this hypothesis,
151The observation that tliyroid UDC of I is approximately 2*5 x 
99biDBG of To in humans has not been previously reported and is
surprising because Wolff (1964) has shovm that for is lower
151 99mthan for I* The lov/ rate of Tc transport into tliyroid
observed in vivo is oonoeiveably a result of the binding of this
radionuclide to plasma proteins (Hays and Green, 1975)»
It is also of interest that Harden and Alemuder (1967) found
153the salivary clearance of I in humans to be 2.1 x the salivary 
clearance of ^^^c* This finding in conjunction with the author's 
ovm data is compatible with a similar ionic transport mechanism in 
human tliyroid mid salivary glands and agrees vzith other studies 
(Wolff, 1964)* Indeed it is likely that both ^^^c and share
a common transport mechanism in these glands.
^^^Tc and inorganic are distributed in the same ena,tomical
compartment in tliyroid (i.e. follicular colloid) and appear to be 
transported into thyroid by the same mechanism. The close ooxTela;bion
obtained between the exit«ra;be constants of and both before
(l<^ p) and after perchlorate injection (K'^p), indicates a further
Kt p
C ■►Kjp
Kjp
NORMAL ^ T c  TRANSPORT
K t p
PERCHLORATE EFFECT
21s Diogranuïiatio ropx'osentation of the effect of
perchlorate on follicular function. Perchlorate 
flratly blocks the tliyroid transport mechanism (c) 
for ^^^0 and by competitive inhibition and 
secondly, exag'gerates the *leak* of unbound radio*- 
nuclide from the follicle. This latter effect, 
demonstrated by an increase in to may
result from a reduction in the follicular electro™ 
chemical gradient induced by perchlorate.
62
basic similarity, namely in ionic diffusion, although was clearly
more active in this respect. In the analysis graph, the slope (ï^p) 
of plot d^/dt/p against T/P was constant and independent of tliyroid 
content of ra.dionuclide (Figure 16). This confiims that îC^ p^ is due 
to simple diffusion of radionuclide through thyroid follicular cells 
and probably results from the concentration gradient between follicle 
and iiiterstitiura. K*^p after perchlorate is larger than by a, 
faotor/2 to 5s however, and appears to represent a different phenomenon. 
The mono-exponential character of the *washout* of both ^^^o and, 
suggests a sudden ‘release* of tliyroid radionuclide followed by 
extremely rapid diffusion. Equivalent animal studies have both 
confirmed that perchlorate magnifies diffusion of ions from follicles 
(Scranton et al, 1969) and suggested (Wolff, 1968) that the effect 
results from depolarisation of thyroid cell membrane mediated by 
loss* The author's results could be in keeping with this theory and 
the hypothetical perchlorate effect has been depicted diagrajnraatically 
in Figure 21.
99mThe analogue computer was found unsatisfactory for To rate 
constant measurement and a poor correlation (r « *86) with results 
from graphic analysis was obtained* In practice, precise curve
fitting was difficult because more was concentrated by thyroid
in the first 2 minutes after injection than could be explained by the 
approximated arterial plasma curves* Although these latter curves 
were approximate, the author is convinced that their inlierent error is 
small and considers it more liîcely that this phenomenon represents 
bolus trapping by tliyroid of unbound plasma in the immediate
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post-injectioïi phase. Further studies of this phenomenon are
being pursued*
In conclusion, this in vivo study of the metabolism of Tc
and in thyroid indicates clearly that tliyroid UDC of is
131an ideal substitute for, and is often preferable to, I clearance
parameters as an index of thyroidal iodide transport. Despite the
undoubted clinical value of the UDC measurement in the
differential diagnosis of thyrotoxicosis, the elaborate protocol 
necessary, coupled with an insensitivity at low clearance rates, 
would seem to preclude its routine clinical use in investigation of 
tliyroid function.
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- CHAPTER 6
üeing a simple directional counting technique, the thyroid 
transport function for and ^^^1 was quantitated primarily
using a combined graphical and digital analysis* Direct and equal 
proportionality found between thyroid unidirectional clearance of 
^ ^ c  and both thyroid net and unidirectional clearance of 
indicates firstly that unidirectional clearance of ^^\c is an 
index of thyroidal iodide transport and secondly, that little if 
any, recently transported iodide is unorganified in normal and 
thyrotoxic thyroid glands* A close correlation obtained between 
thyroidal exit*#rat@ constants for ^ ^ c  and both before (K^), 
and after perohlo%%te (K*g^), indicates a similar ionic diffusion 
pathway from thyroid for each radionuclide. Perchlorate magnified 
this diffusion by a factor of 2 to 3*
63
CHAPTER 9
; -mvym
TimoXD UPTAKE OF TEGHmXUM-99in
This chapter describes a method for measuring the thyroid uptake 
of perteclmetate- using directional counting. Accuracy of the 
tecîmique is assessed and possible roles for the measurement in 
clinical investigation are discussed,
IWTHODUCTXON
In Chapter 8, thyroid unidirectional clearance of pertechnetate-^^**^c 
(^^Ic) was shovm to be an accurate index of thyroidal iodide transport. 
This index vjas considered unsuitable for routine use in c3.inical 
investigation since its measurement was both time consuming and insensitive 
at lovT clearance rates* As an alternative index of thyroidal iodide 
transport, a simple method has been developed for measuring thyroid 
uptal£0 of using directional counting*
Tliyroid uptake of Is an accepted clinical index of thyroid
function but is usually measured using quantitative scintiscanning 
techniques (Shimmins et al, 1969a; Williams et al, 1971) or expensive 
gamma-scintillation cameras (Hurley et al, 1972). These specialised 
tecliniques are time consuming unless computer facilities are available 
(De Garreta et al, 1968).
Precise measurement of the uptake of thyroid using
directional counting requires correction for extrathyroidal neck radio­
activity (ETA). This is of the order of 3 - 6% of administered radio­
activity with the X.A.E.A* collimator (Ghimmins et al, 1969a).
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Prôvioue workers found accurate measurement of ETA difficult 
with directional counting systems* Since the normal uptake
of thyroid is only 1 - 3# of dose, inaccurate uptake values were 
invariably obtained# Andros et al (1963) had limited success with 
a 'washout* technique using oral potassium perchlorate while Van't 
Hoff et al (1972) approximated ETA and found the test useful only 
when thyroid uptake was above normal*
The author's technique for measuring thyroid uptake of 
eliminates the necessity for separate ETA measurement# Having reduced 
the contribution of ETA to total neck counts with special collimation 
(Chapter 5), the amount of dischargeable from thyroid, is
measured after its 'washout' by Intravenous sodium perchlorate injection• 
These adaptations reduced the range of uncertainty in measurement of 
this type of uptake of by thyroid from 4Qg6 to 13$^ *
Results of studies on 119 patients are presented and possible 
roles for this test in thyroid Investigation are discussed#
MATERIA18 AND METHODS 
Thyroid uptake of 13 minutes after injection, was measured
in 99 patients# 27 normal volunteers with no evidence of thyroid 
disease, 2Ô patients with untreated thyrotoxicosis, 15 patients with 
primary myxoedema, 10 hypothyroid patients with Hashimoto's disease 
(the criterion for diagnosis was the presence of a strongly positive 
precipitin test for serum antithyroglobulin antibody), 16 patients 
with simple goitre and 3 patients with Pendred's syndrome*
1. THYROTOXICOSIS
2. NORMAL THYROID
3. HYPOTHYROID I.V.
50mg.NaCI O 4
Tc"" I.V.
g  10
m
Standard
oi
LU
LU
TIME -  MIN.
ï':igtLTG 22 8 A trace record of neck radioactivity during measure­
ment of the thyroid uptake of perteohnetate-^^^fc in
0, thyrotoxic (l), euthyroid (2), and hypothyroid (5)
99fflpatient, ‘Washout* of thyroidal Tc in each 
BUhject follows the XV injection of 50 mg of sodium 
perchlorate. The arrows indicate the times of 
injection of and perchloratej system calibration
is shovoï with a dose standard in a thyroid phantom.
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înstrumeatation
The direetioael counting system, counting equipment and recorder 
have been previously described (Chapter 8)# The system was calibrated 
using a standard ot in a thyroid phantom*
Procedure
patients lay on a couch, the special collimator was carefully 
positioned over the thyroid and 400 # 800 uOi ^^^c was injected 
intravenously (Figure 22), Thyroidal plus extrathyroidal radio­
activities were continuously recorded for 15 minutes* Sodium perchlorate 
(go was then injected intravenously (IV) and recording of total 
neck radioactivity continued until ^ ^ c  ^washout* from thyroid was 
complete* this usually toc^ 1 0 -15  minutes* The difference between 
total radioactivity in neck before and after perchlorate discharge was 
considered to be thyroid uptake of though it required a correction
for fall in SiTA during the period of discharge* This correction factor 
was found by measuring the fall in ETA between 15 and 30 minutes after 
an IV injection of ^ ^ c  in 10 patients who had been given perchlorate 
orally, 1 hour before radionuclide. The correction was found to be 
0*12# of administered dose (ISD * + 0*C5) for a 10 minute discharge 
and 0*1% (ISD w + 0,07) for a 15 minute discharge,
a further 4 normal and 16 thyrotoxic patients, recording of 
thyroid uptake and plasma radioactivity of ^^*To as described in the 
previous chapter was combined with a perchlorate discharge at 15 
minutes, thereby allowing direct comparison between thyroid unidirectional 
clearance and uptake measurements.
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EandoiQ errors includes
1. Statistical variation in output voltage of ratemeter 
Found to be 
2# Repositioning of patients
Allowing a reproducibility of collirnator-neck distance of 
^0,5 cms, uptalce was in error by 
3* Injection calibration
Inaccuracy in estimating ^^^Tc dose resulted in the standard 
being in error by approximately 3%#
Systematic errors include:
4. ETA fall during perchlorate washout
Use of the correction factor described resulted in an error 
dependent on the absolute thyroid uptalce of For an
uptal^ e of 0»^% dose, this error was 20^, For an uptake of 
1% dose, it was 10^ & and for an uptalce of 10^  ^dose, the error 
was 1%»
3# Non-dischargeable thyroidal
OOfM
The absolute amount of Tc dose retained by thyroid after 
perchlorate in 11 tliyrotoxic and 7 normal patients was 
approximately 0*3S^  j; 0*3 (mean + ISD) and the error in measure­
ment of tliyroid uptake was 12,0% 10*0 (mean ^ ISD),
99mTotal random error in the To ui)talce and discharge phase were 
measured separately in each of 10 subjects and this error which 
includes technical inaccuracy and day to day variation in individuals 
was 10 - 13%#
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THYROIDAL UNIDIRECTIONAL CLEARANCE OF
in
25: ïMs figure shovrs the correlation between tliyroidal uptake
and unidirectional clearance of pertechnetate-^^^o 
meaoured in 20 patients* The upper broken regression 
line, j 0#10y% -j* 0,19 and r = 0*98, relates to 7 patients 
(closed circles) with 0,05^  ^  0*10 and the lov/er
broken regression line, y = 0.0695% -i- 0*96 end r = 0.95 
relates to 11 patients (open circles) with 0.10 ^
^  0.15. Tv;o patients are shown where Kgip^ 0.15.
The unbroken regression line for all patients was y =
0.095% - 0.46 with r " 0.90.
TABJJl 7
THE RELATIONSHIP BETl'/EEN THYROID UPTAKE,
UNIDIRECTIONAL CLEARANCE AND EXIT-RATE CONSTANT
OF 99m,Tc IN EUTHYROID AND THYROTOXIC SUBJECTS
TECHNETIUM-99m
THYROID UNIDIRECTIONAL 
PATXjüNT CLEARANCE (L/rnin)
15 MINUTE THYROID 
UPTAKE % DOSE
THYEOID^iL
1 0.250 22.7 0.085
2 0.056 5.1 0.094
5 0,056 4.6 0,080
4 0.100 14.0 0.055
5 0.052 5-8 0.095
6 0.072 6.2 0.080
7 0,265 19.5 0.095
8 0.055 6,0 0.105
9 0.105 8.8 0.105
10 0.060 4.2 0.150
11 0.150 8.9 0,140
12 0.064 5.4 0.150
15 0.019 1.5 0.105
14 0.066 6.7 0.110
15 0.175 12.5 0.150
16 0.090 7.5 0.105
17 0.054 5.4 0.140
18 0.068 5.8 0.125
19 0.115 5.8 0,26
20 0.052 5.5 0.29
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RESULTS
Uptake of by the thyroid, 15 minutes after injeotlon in
the 6 groups of patients,is shown in Figures 23 and 24. Résulta 
are summarised in Table 6 *
The relationship between thyroid unidirectional clearance and 
the 15 minute uptake of ^^®Tc in the 4 euthyroid and l6 thyrotoxic 
patients is shown in Figure 25 and the complete data in Table 7.
The regression line for 7 patients with 0.Q5 K^p 0.10 was
y ce 0.107 X 4- 0.19 with r « 0.978# The regression line for 11
patients with 0,10 ^ 0 . 3 5  was y « 0.0695 % + O.96 with r «
0 .95* The regression line for all 20 patients studied was y »
0.095 3C 0,46 with r * 0 .90*
Plasma ^^ *®Tc concentration at 15 minutes in 4 euthyroid patients,
was 0.091 4- 0.019 (mean 4 ISD) and in I6 thyrotoxic patients, was
0,087 t 0.016 (mean t lSD)c fract. dose/litre.
DISOUSSION
This directional counting technique for precise measurement of 
thyroid uptake of (strictly the 'washout * of tliyroidal
has the advantage of technical simplicity over quantitative scanning 
procedures* Moreover, separate measurement of ETA is not required 
and so a major source of error is eliminated* The resultant index 
is both reproducible and sensitive enough to be measured in hypothyroid 
patients. Ranges for normal and diseased subjects appear to be 
similar to those reported by other workers (Goolden et al, 1971$
McGill et al, 1971) who used quantitative scintiscanning, despite the
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small systematic error of non«dischargeable In clinical terms
it appears that non«dischargeable is unimportant.
The close collimation used to reduce the contribution of ETA to 
total neck counts restricts application of the technique to thyroid 
glands under 100 g. This minor disadvantage is rarely a problem in 
practice•
There are two main disadvantages of the protocol. Firstly,
administration of perchlorate and resultant blocking of thyroidal
iodide transport will delay additional dynamic studies of thyroid
function for at least 24 hours. Secondly, intravenous injection of 
99mTc and perchlorate is necessary because use of the more convenient 
oral route is accompanied by the major systematic error of variable 
alimentary absorption (Alexander et al, 3,969).
The ^^*\c uptalce is clearly a resultant of two dynamic processes; 
^^^c influx imto and efflux from, thyroid. Since thyroid and plasma 
^^"^c pools are in equilibrium at 13 minutes in the majority of 
patients,
C.P(ti) = K^p T(ti)
where G = thyroid unidirectional clearance of ^^^Tc
P(ti) = plasma concentration of ^^^^c at 15 min
99ms exit-rate constant of thyroid for Tc 
T(ti) " thyroid content of ^^^^c at 15 min
Therefore;
T(ti) " where ti = 15 min
TP
The thyroid uptake of ^^*\c at equilibrium is therefore directly
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proportional to both «nldlreqtional claaraace and ambient plasma 
concentration of and inversely proportional to p(ti),
which is mainly dependent on plasma volume, may £iloo be affected by 
a variable thyroid unidirectional clearance 0* also varies
between patients though 90^ of subjects had values between 0,Q5 
and 0.15 min**^ . Ignoring the variability of plasma however,
it is clear that the relationship between uptake <T(ti)) and 
unidirectional clearance (G) cannot be linear and any regression line 
obtained between those parameters will depend in part on values 
in the sample population studied (Figure 25). Since a majority of 
patients had K^p values within a small range, the error in estimating 
unidirectional clearance from the uptake in any one patient is 
unlikely to be great if the regression line for the whole population 
is used. ThJaa particular inaccuracy does indicate, however, that 
the uptaîce measurement will be most valuable for sequential assessment 
of iodide transport in the same patient where and possibly P(ti), 
may be assumed constant.
The results have confirmed reports of other workers (Goolden et
al, 197X5 McGill et al, 19715 Van't Hoff et al, 1972) tliat thyroid
uptake of is of value for diagnosis of thyrotoxicosis. Uptake
of ^^*^0 may overlap into the thyrotoxic range, however, when other 
thyroid pathology with hyperactive iodide transport is present (e.g* 
Hashimoto's disease)#
There are specific situations where use of is preferable to
that of radioactive iodine* In view of the small radiation dose to
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thyroid and whole body (Be Garreta et al, 1968) and more suitable 
counting oharacterintics, it should replace I for measuremente of 
thyroid uptake in children and pregnant women, Since thyroid
organification of radionuclide Is minimal, kinetics are not
influenced by concurrent administration of thiourylone drugs such 
as carbimaaole# uptake of thyroid can therefore be used to
follow the progress of thyrotoxic patients on drug treatment (Goolden 
et al, 1971) and can even imdioate thyroid suppreosibllity (Shimmias 
et al, 1971),
In conclusion, the technique described provides a useful simple 
alternative to quantitative scintiscanning and sointillatlon-c&mera 
procedures when measurements of the thyroid uptake of are
thought to be useful in clinical diagnosis and research*
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a m m w  -, o i m m n  9
The 15 minute uptake of by thyroid was meaeured using a
simple direotional counting technique whereby the washout of 
thyroidal was quantitated after intravenous perohlorate injection.
Results from patients with various thyroid disorders compared 
favourabSy with those obtained by other workers who used quantitative 
scintiscanning and scintillation camera techniques. Thyroid uptake 
of was found to be largely proportional to the unidirectional
clearance of ^^"^c though an error in this relationship resulted from 
inter*patient variability of thyroidal K^p* It is suggested that the 
role of ^^^Tc Uptake in thyroid investigation should be primarily in 
sequential assessment of thyroidal iodide transport in the same 
patient where may be assumed constant.
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CHAPTER 10
EFFECT OF RADIOACTIVE XODTO THSRAPY ON THE 
ACTIVITY OF IODIDE TRANSPORT AS MEASURED 
BY THYROID UPTAKE OF TBCmETIUM-99m
INTRODUCTION
A vast literature on radioactive lodlne^l^l (^^^I) therapy for 
thyrotoxicosis spanning two decades reflects the difficulties in 
providing a permanent remission of thyrotoxicosis with this treatment 
without a cumulative rising incidence of iatrogenic hypothyroidism 
with passage of time# .Workers have attempted to predict the eventual 
outcome of therapy by performing in vivo thyroid function tests 
using tracer amounts of (Soloy et al, 19495 Larson, 1953) and 
(Einhorn ot al, 1961; Binopoulos et al, 19635 Buchanan et al, 
1963) at short intervals after treatment. Although the results of 
such studies are instructive and demonstrate the effect of radiation 
therapy on aspects of thyroid function, therapeutic success has been 
limited by the variability in thyroid radiosensitivity from patient to 
patient.
Greig ot al (1969) have recently pioneered the use of radioactive 
iodine-H.125 (^^^1) as an alternative therapeutic agent* The initial 
hypothesis (Gillespie ot al, 1970) that low energy B irradiation from 
would affect hormone synthesis more than cell replication has 
been confirmed in animal studies (Gross et al, I968? Greig et ol, 1970)< 
Prolonged clinical trials arc at present in progress to determine 
whether the unusual microdosimetry of ^^^I will reduce the cumulative
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incidence of post-^ -therapy hypothyroidism (McBougaXX et al, 1971;
Werner et al, 1970; Bromner et al, 1973)#
125The effect of I treatment on thyroidal iodide transport has
not boon studied in detail (Lowitus et al, 1971)# Thyroid uptalm of 
99raTc was therefore measured 15 minutes after injection, in thyrotoxic
patients before, and at intervals after, treatment with or
Since the photon energy of (l40 ICeV) is higher than that of
(25 - 35 KoV), studies were possible immediately following
151therapy. Similar early studies following I therapy were precluded
by the iiigher energy (360 Kev) of this radionuolide and in tlms group
of patients, assessment began 1 - 2  months after therapy. Results
on 33 treated thyrotoxic patients are presented and correlated with
the clinical outcome 8 - 1 0  months later*
mTEHIALS AND mTHODS
Thirty-three patients were studied and in all, a clinical
diagnosis of thyrotoxicosis was confirmed by a 24 hour uptaite of 
1?7and serum PB "I* All patients were treated as out-patients and each
had diffuse tliyroid enlargement with an approximate thyroid weight of
between 25 and 75 g. The therapy dose of "^^ 1^ or administered
127 —orally, contained approximately 60 ng and was calculated on an
empirical basis depending on approximate gland weight* Since 
qualitative data on the radiation effect was required, estimates of 
radiation dose to each gland were not made* Thirteen female patients, 
with a mean age of 46 years (range of 39 62 years), were given
7 4^ 4 mGi (mean ❖ ISD) in 18 therapy doses* 'B/enty patients,
Z mala and 18 female with a mean age of 45 years (range of 36 - 54
I■o 131| GROUP 1 -  HYPOTHYROID
MONTHS -  POST THERAPY
Figure 26 s Tliyroid uptake of measured sequentially in 4
patients who became hypothyroid after * I thera,py«
indicates commencement of tliyrox:lne,
-  76 -
years), were given 12 ^  4 mOi (mean j; ISD) in 21 therapy doses*
ThjToid function was measured with a serum and tliyroid
uptake of (Chapter 9) before and regularly after treatment.
IPR l’il
Assessment began 2 - 4  days after I and 1 - 2  months after I 
therapy.
125Thyroid content, of therapy I following treatment was measured
at weekly intervals for 4 - 6  weeks in 12 patients using an adapted
directional counting system. This consisted of a standard IAEA
collimator with a 1.0 mm thick copper sheet at a standard distance
between the crystal and patient to reduce intensity of radiation from
treated glands. Suitable therapy dose standards of in a thyroid
phantom were used for system calibration.
The biological half-life of thyroidal was calculated by
125plotting the fraction of 24 hour ’ thyroid uptalce which remained
in the gland on a log-linear scale with time. The time required for 
125
thyroid I content to fall to 50^ of the 24 hour uptake was 
considered to be the biological half-life (T^ Biol).
KE5TJIÆS
Data from and treatment populations has been grouped
depending on the clinical outcome of therapy at 8 - 10 months after 
treatment. Variation in thyroid uptalee of ^^ "^ To with time after 
therapy is shown in Figs. 26 to 5I and the data is summarised in 
Figs. 27b to 30b.
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Figure 27ai Thyroid uptake of moaoured sequentially
1^1after I therapy in 7 patients who remained 
thyrotoxic.
Figure 27h@ Siuïmiary of sequential assessment of thyroid
function in the 7 patients vfho remained 
151thyrotoxic after I therapy. The mean 
ISD of each parameter in the patient group is 
illustrated.
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Flgwo 28a; Thyroid uptake of Measured sequentially
after ^^^1 therapy in 5 patients who heoaine 
euthyroid* The patient whose uptake increased 
after therapy had a major defect of iodide 
organification in thyroid and was clinically 
and hioohemically eutî^roid throughout this 
period of time*
Figure 28b: Summary of sequential assessment of tliyroid
function in 5 patients who became euthyroid 
after therapy* The mean + ISD of each 
parameter in this patient group is illustrated.
77
precipitate fall in. uptake developed hypothyroidism within 2
months* In 2 other patients| an apparent gradual fall of 
uptake over 5 - 9  months resulted in hypothyroidism*
Persistent thyrotoacicosiei Fig* 2?a shows the following 
featuresI
1* In 3 patients I uptake fell to 40 #. 70% of pre-treatment
value within 2 months. uptake remained at the new level
in 2 while in the other, the pre-treatment level was re-attained 
within 5 months.
2* In 5 patients there was little change in uptake following
therapy while in 1 other, the uptako gradually fell to 60% pre­
treatment value at 10 months.
Fig. 27b, which summarises the data, demonstrates a fall in mean 
uptake at Z months with rise thereafter*. The mean 
was virtually unchanged over the period of observation*
Group 3
Sluthyroid result: Fig. 28a shows the follov;ing features*
1. In 3 patients, uptake fell to 15 - of pre-treated
value within 2 months* Each patient was euthyroid at this 
time and was still euthyroid with 15ttle change in uptake
10 months after treatment*
2. One patient was seen to be euthyroid 3 months after theiapy 
with no change in uptake* The uptake fell slightly at
10 months*
125| GROUP 4 EUTHYROID
4-6  10-14 28-56
DAYS POST THERAPY
84-112 168-224
Tc uptake 
PB 1271
Pre — 4 —6 10—12 1 —2
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Figure 29a; Thyroid uptake of meaeured sequentially
125
after I therapy in 9 patients who became 
euthyroid.
Figure 29hs SuiMary of sequential assessment of thyroid
function in 9 patients who became euthyroid 
125after I therapy. The mean ^  XS3) of each 
parameter in this patient group is illustrated.
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3» One patient demonstrated a rise in uptake at 2 months
after therapy despite the presence of clinical outhyroidism 
at this time. The uptake then fell gradually, until it 
approximated the pre-treatment level at 10 months* This 
discrepancy between uptake and clinical state was accounted for 
by a demonstrable defect of tkyroidal iodide organification 
COhapter 13).
Fig* 28b, which summarises the data, demonstrates a fall in
both uptake and by 2 - 4 months and the relative
127 ■ 'constancy of PB , I thereafter*
m R A p y
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Euthyroid result; Fig. 29» shows the following notable 
features#
1* In all patients studied, there was a reduction in uptake
at 2 - 4 days to 40 - 7O5I of pre-treatment value*
2. In 3 patients, uptake continued to fall with time* By
8 months it stabilised at 10 - 30?^  of the pre-treatment value. 
3* In 6 patients, ^^*^c uptake increased between 2 - 8  weeks then 
fell once more, stabilising at 10 - 40^ > of the pre-treatment 
value at 8 months.
Fig* 29b, which summarises the data, demonstrates an initial 
precipitate fall in ^ ^ c  uptake on the second day and further 
reduction over succeeding months* shows a delayed
fall*
125| GROUP 5 PERSISTENT THYROTOXICOSIS
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Figure Thyroid uptake of measured sequentially
125after I therapy in 9 patients who remained 
thyrotoxic.
Figux'e 50hs Bummary of sequential assessment of tliyroid
function in 9 patients who remained thyrotoxic 
after therapy. The mean ^  ISD of each 
parameter in this patient group is illustrated.
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53. Î 5?îi^ oid uptake of measured sequentially after
125I therapy in 4 patients ?/ho became lnypothyroid*
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Qroup 5
PerelGtant thyrotoalGosis; Fig, ^Oa shov;s the following notable 
features:
1, fhree patients showed little ohange in ^ ^To uptaice following 
therapy,
£• In 6 patients, there was a fall in uptaîïe within 2 - 4  days
to 50 « ?C^ of the pre-treatment value. In 4 of these patients, 
uptake rose after 6 days and reached 75 " 90^ 6 of the pre-treatment 
value by 4 months, I*i 1 patient^ the uptalce persisted at the 
value attained 2 days post-therapy and in the other patient it 
rose to 25(^ 6 of the pre-treatment value by 4 months,
Fig# 50b, which summarises the date., demonstrates little cbonge 
in mean with time though a modest reduction in mean
uptake is seen at early intervals following treatment.
Group 6
Hypothyroid results Fig* 51^  shows the following notable 
features ;
1. In 2 patients, the initial fall in uptoice to 50/* of the
pre-treatment value within 4 days was maintained for 1 - 2  months, 
thereafter, 1 patient became liypothyroid within 4 months with a 
further fall in uptalce and the other within 10 months,
2, In 1 patient, the uptalce fell only from the tenth day
post-therapy. Thereafter, the uptalce fell gradually till 
hypothyroidism developed at 8 months*
Tpc
BIQLOGlGAh HAIF-LIFB OF THYROIDAL
The biological half-Hfe of thyroidal ^^^1 in 12 patients was
80-
& 60-
w 40-
20-
) 20 30
Days after therapy administration.
40 50
PJ.giire 52s ïhls figure illustrates the progressive Increase in 
total radiation exposure of thyroid from an average 
thero.py dose of Approximately 11^ of total
radiation is deposited :1n 2 days and O^fo '1m  15 days,
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l6 days 2 7 (18D)# The derived effective half-life (T^ eff) was 
12.6 days (Appendisc 3).
Using the calculated off with the mean 24 hour uptalce of 
therapy close in the 12 patients (i.e. 68?^ ), the average increase in 
total radiation exposure of thyroid with time can he calculated 
(Appendix 3) and lias heon portrayed in graphical form (Figure 32),
It can be seen that, on average, 3P/6 of total radiation is 
deposited in 13 days and at 30 days, 9 %  of oxpositre is complete,
IG80UG&I0M
Workers who studied thyroid function in vivo following
therapy (Larson and Ragnhult, 1933Ï Wyant, 19.53^  EiJihom and Hastad,
1961; Binopoulos et al, 3.963) clearly demonstrated that thyroid
uptakes of 3 weeks after therapy, were reduced from pre«treatment
13'1levels in most cases* Although reduction in I uptalce at this time 
was most pronounced in the group of patients eventually becoming 
euthyroid or iiypotliyroid, attempts to predict the clinical outcome in 
individual patients by graduating tills reduction in uptalce were 
unsuccessful. . Indeed 2 3 niontlis after therapy, the uptalce usually
rose to pre-therapy levels in patients requiring re-treatment and 
rema:lîiod at a low level or became lower in patients eventually becoming 
euthyroid or Ijypothyroid*
131In this investigation of patients after I therapy the author 
has confirmed firstly that reduction In uptalce at 6 - 8 weeks
after therapy is greater ixi those becoming euthyroid or liypotlTyi’oid, 
and secondly that prediction of clinical outcome is inaccurate where
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individual patients are concerned unless studies are performed 4 « 6
months after therapy* An interesting feature has been the elevated
uptalce after therapy in the patient who developed a defect of
thyroidal iodide organification* ,This particular radiation-induced
dyshormonogenesiB will be discussed ful3y in Chapter 14*
125Data from patients following 1 therapy are more valuable and
the
allow closer insight Into/effect of this radiation on thyroid function*
Threo main features emerge* First.1y, an appreciable reduction in
^^Tc uptalce observed 2 days after therapy in most patients indicates
an immediate radiation effect on follicular function* As depicted in
Figure 32, only a mean 11^ of the total radiation dose to thyroid
would have been deposited at this time* It seems plausible that
this initial effect on thyroid function is related more to the therapy
doso-rato than to total dose delivered at that time* Secondly,
uptalce appears to incroaso 6 - 1 2  days after therapy; v;hile it may
return to pro«therapy levels in those requiring re-treatment, it
usually decreases again in those becoming ©utliyroid* It is probable
99mthat this second decrease in ^ Tc/is primarily related to the total 
radiation dose delivered to thyroid* Thirdly, a slow reduction in
uptalce over 2 - 6  months after therapy in those patients becoming 
hypothyroid is clearly iyidistinguishablo in the early stages from 
those destined to remain euthyroid*
125These results suggest that after 2 months, the effect of I 
radiation on tliyroidal iodide transport, closely parallels that of 
Following therapy with either radionuclide, one clearly must
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wait 4 - 6 months before a uptalce or will reliably
indicate residual function in the thyroid remnant, The observation 
127that PB ” I measurement is valueless for predicting clinical outcome 
at early intervals after therapy was first made by Larson (1933) and 
reflects the slow turnover of total body tliyroxino *
The results of this pilot stud^ have enabled the author to
1P5
formulate a simple hypothesis for the mechanism of action of " I  
radiation on thyroidal iodide transport and possibly on total thyroid 
function* In ossonco, the immediate effect of tliis radiation would 
appear to be a reduction of iodide transport across the basal membrane 
and may be termed * functional radiosonsitivity *. TMs is possibly 
doso-rate related and mainly reversible* The delayed, ciMUlative 
effect on iodide transport may be related to total radiation 
deposition in the gland and will x>robably bo irreversible. The not 
result of this latter effect will be ’radio-destruction* of oolls 
and reduction in the functional coll mass of tl^ yroid* The observation 
that one patient showed little evidence of functional radiosensitivity, 
yet later developed hypothyroidism (Figure 31& ) might indicate that 
functional radio-sensitivity mid radio-destruction are potentially 
distinct responses of tliyroid to radiation* Further animal and human 
in vivo studies are required to clarify those points*
From the practical aspect, it is clear that a combination of 
p^l27^ and uptake at 4 months after therapy will roliably indicate
the eventual clinical outcome in the majority of patients* While 
not ideal, this will be of practical importance when attempts are
83 -
125made to reduce the incidence of post ' 1 therapy liypothyroidism by
administration of fractionated therapy doses rather than the single
doses currently employed* Further studies are clearly required to
133determine whether fractionation of Î therapy will control the 
intractable problem of hypothyroidism after treatment*
smmhm » cmptbr lo
Tbyzoid uptake of 13 minutes after injection, was
measured in thyrotoxic patients before, and at intervals after, 
treatment with or m  a detailed study, the radio­
biological effect of on thyroidal iodide transport was found 
to be blphaaio with an immediate, reversible effect possibly related 
to rate of deliveiy of treatment radioactivity and a delayed, 
irreversible effect,possibly related to total deposited radioactivity 
The results argue that measurement of ^^^0 uptake 4 months after 
therapy will give a reliable indication of treatment effectiveness 
in a majority of patients*
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SECTION 4
STUDIES OF TmOIDAL IODIDE ORGANIFICATION 
IN VIVO USING RADIOACTIVE lODTJE-lJl
Cioapter 11
Chapter 12
Chapter 1$
Chapter I4
Chapter 15
The ilntravenous perchlorate discharge test: 
theoretical aspects, teclinical development 
and clinical application 
The organification rate of thyroidal radio­
active iodide-131Î measurement in vivo 
Hashlmoto’s diseases its differentiation 
from simple goitre using the intravenous 
perchlorate discharge test 
Defective iodide organification in thyroid 
following therapeutic irradiation with 
radioactive iodine-131 or 125 
Familial goitrous hypothyroidisms 
investigation of three siblings
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CHAPTER 11
THE . XNTimVENOUS PEROtlLQRATE .DIBOHAROS TESTt 
THEORETICAL ASPECTS^ TEQHHIQAL mVELOPMENT 
AND CLINICAL APPLICATION
In this chapter, a simple in vivo technique for detection of 
unorganlfied radioactive iodide in thyroid is developed and assessed 
with the aid of small-animal studies.
INTRODUCTION
Detection of unorganified thyroidal iodide with the conventional 
oral perchlorate discharge test assists diagnosis of conditions such 
as Hashiaoto*e disease, pendred’s syndrome and iodide goitre, where & 
defect of iodide organification is present. In the conventional test, 
potassium perchlorate is given orally in a dose of up to one gram, up 
to 2 hours after oral administration of radioactive iodine-131 
to the patient. Thyroid content of is monitored by directional 
counting and, if unorganified iodide is present, a discharge of inorganic
from the gland is seen after perchlorate administration. Tho 
insensitivity of this standard test, however, mokes detection of small 
amounts of thyroidal inorganic iodide unreliable and this feature is 
reflected in a lack of unanimity among protagonists of the oral test 
regarding methodology and criteria for its Interpretation (Fraser et 
al, I960; Floyd et al, I960; Baschieri et al, 1963; Stewart and 
Murray, 1966).
A discharge test has been developed using intravenous perchlorate;
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Figure 55® îîÿpûthetioal representation of the partition of XV 
into organic and inorganic thyroid pools as a 
oonsequonoG of the tliree-compartment model,
(a ) liajor defect of iodide organifioeÆions- with
organifioation rate of approximately zero, there is
13'}a large persistent inorgan.ic pool in tliyroid,
(b ) Hinor defect of iodide organifioations-* with 
organification rate approximately 0«20, the large 
inorganic pool jn thyroid present Initially 
diminishes rapidly in size with time#
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it is simpler, more rapidly performed and possibly more sensitive 
than the oral test* Results obtained using this new test in patients
with
with various thyroid disorders are contrasted / data from rats which 
were studied using a similarly conceived discharge technique*
BASIC KBCSTICS
As described in Chapter 4, thyroid transport of plasma iodide
and its subsequent organification in the gland can be considered
theoretically in terms of a three compartment model (Berson and falow,
1955| Wellman and Reed, 1959; Robertson et al, 1971)• Basically,
thyroid unidirectional clearance of plasma iodide (the trap) pulls
iodide into the gland and the fraction of this trapped iodide which
is organified depends on the organification rate* With normal iodide
organification, no unorganified thyroid iodide can be demonstrated
(Berson and Yalow, 1955) and the organification rate approximates
unity. With a reduction in organification rate, less trapped iodide
is organified and more accumulates as inorganic thyroidal iodide*
Correct timing of perchlorate administration is important in
performing a discharge test* Hypothetical thyroid uptake patterns
of ^^^1 following its intravenous injection are illustrated
diagrammatically in Figure 55# In the presence of a major iodide
131organification defect, most trapped ^ I remains in the gland as 
unorganified ^^^I-iodide over a period of several hours* Perchlorate 
administration one or two hours later will discharge a large, easily 
quantitated fraction of total thyroid radioactivity* When the iodide 
organification defect is minor, however, thyroid content of unorganified
Ç« 
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Figure 54 ï Trace record of neck radioactivity during the IV
perchlorate test in a normal subject is sho\m in
151section A folloY/ing the ' I standard recording*
Since iodide organification was normal, no discharge 
of was seen after IV perchlorate* Quantita.tion
of ETA is illustrated in section B following IV
131_
injection of a second 25 uGi dose Of I*
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131l-iqdide is high only in tho first few minutes after its administration.
  yry
organi^-cation of trapped I but
^^ I^-iodide 
ira3J.eling 
m  is therefore 
.efeot where
Injection io
&ck radioactivity 
ter. Special 
trathyroidal neck 
per cent dose 
ids under 100 g* 
fihich was connected 
■enous perchlorate 
Figure 34. After 
uGi ^^^1 was 
recorded continuously 
rchlorate was 
radioactivity, which 
lea, vjas continued 
was calculated as the
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difference between total neck radioactivities at 10 and 20 minute»*
To determine whether the observed perchlorate discharge from 10
to 20 minutes was priraari3y due to discharge of thyroidal or to
reduction in JE3TA which occurs with time (Chapter 5)# the fall in
contribution of ETA to total neck counts was measured between 10 and
20 minutes after administration by Injecting a further 25 uGi
131
I intravenously at the end of the perchlorate test in 25 normal 
control patients* The procedure is shown in part (B) of Figure 34*
It was assumed that total neck radioactivity from the initial dose 
of remained constant throughout the procedure and this level was 
used as a base-line* The increased neck radioactivity following the 
second dose was considered extrathyrotdal since thyroid trap was 
blocked by perchlorate* Fall in this additional neck radioactivity 
was quantitated in percentage dose units between 10 and 20 minutes 
after the second injection and it was assumed that this
measurement approximated the fall in contribution of ETA to total 
neck counts which would occur during the period of perchlorate discharge, 
The intravenous perchlorate teat was performed on 29 patients 
without thyroid disorder, 12 patients with untreated thyrotoxicosis,
16 patients with histologically proven Hoshlmoto’s disease and 5
patients with Pendred*s syndrome* No normal control subject had
127 . 131
thyroid tissue palpable and each had a RB I* 24 hour I thyroid
uptake and 48 hour result in the normal range* Each thyrotoxic
patient, whose ages ranged from 30 - 50 years, had uncomplicated
Graves* disease*
Figure 35® Anatomical relations of an enlarged rat thyroid.
When performing hemithyroidectomy, care must be 
exercised to remove the small strap muscles which 
can be cleairly seen overlying the lateral aspect 
of each thyroid lobe.
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Faix in ETA from 10 to 20 minutes was measured in 23 normal .
control patients#
In subjects with thyrotoxicosis, îfétshimoto*® disease and Fendrad*s 
131syndrome where I ETA was not measured after the perchlorate test,
the approximate thyroidal uptake at 10 minutes was calculated by 
subtracting 2% administered radioactivity, representing the 10 minute 
ETA, from total neck radioactivity at this time (Chapter 5)#
Random errors of the technique were described in Chapter 5#
Total random error of neck radioactivity measurement at 10 minutes 
was 20 - 23?^ *
(b) Rat In Vivo study
Male Oprague-pawley rats weighing 100 • 200 g were fed a normal 
diet# Following anaesthesia with Avertln # 1#5 ml of a 2*5^ solution 
intraperitoneally - the <R) femoral vein was exposed by dissection# 
Perchlorate Group
10 uOi in 0*2 ml saline was injected intravenously in each 
rat at time 0* The thyroid gland was exposed 2 minutes before 
perchlorate injection (Figure 35)# 10 mg of sodium perchlorate in
0*1 ml was injected intravenously at either 4, 8 or 20 minutes after 
^^^1 in groups of 9 rats# Immediately after perchlorate injection, 
the (l) thyroid lobe was rapidly dissected from trachea, a procedure 
taking approximately 30 seconds. The excised lobe was weighed on a 
torsion balance then placed in a sample tube containing 2 ml sodium 
hydroxide in preparation for counting* Digestion of the thyroid by 
alkali allowed more accurate counting of the tissue radioactivity*
The (r ) thyroid lobe in each rat was removed 6 minutes after
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Fif^re 57® ÏY/enty minute perchlorate test results in patients 
i/itli histologically proven Hashimoto*s disease (l6) 
and in patiente with Pendred*s syndrome (5)*
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perchlorate injection since a pi’eXiminary otudy had indicated that
131
discharge of thyroidal I was completed within this time* This 
lobe was weighed and prepared for counting as before*
Controi Group
Following intravenous as before in each rat at time 0, both 
thyroid lobes were removed simultaneously at either 4, 8 or 20 minutes 
after in groups of 4 rats. Each separate lobe was weighed and 
individually prepared for counting. In a further 8 rate, the (h) 
thyroid lobe was removed 4 minutes after injection and (R) lobe 
6 minutes later without perchlorate administration. lobes were 
Individually weighed and prepared for counting as before*
Samples were counted 24 hours after the experiment in a well-type 
scintillation counter under standard conditions*
Human. iStudy
figure 36 In the 29 control patients, absolute thyroid radioactivity 
at 10 minutes was 5*1 4 2*0 per cent administered dose (mean + ISD) 
end perchlorate discMrge between 10 and 20 minutes was 0*11 + 0.15 
per cent dose (mean ^  ISO)* In the 12 patients with thyrotoxicosis, 
approximate thyroid radioactivity at 10 minutes was 19*9 f 10*5 per 
cent dose and perchlorate disclnarge was 0.05 ± 0.06 per cent dose*
Fiffure 37 In the 16 patients with Hashimoto^s disease, approximate 
thyroid radioactivity at 10 minutes was 6*1 + 2.8 per cent dose and 
perchlorate discharge between 10 and 20 minutes was 2.1 + 1,2 per cent 
dose* la the 5 patients with Pendred^s syndrome, approximate thyroid 
radioactivity at 10 minutes was 19*4 + 7*0 per cent dose and perchlorate
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Figitco 38® Results from the adapted perchlorate teat procedure 
jju normal non-goitrous rats. Thyroid concentration 
of is sho\m before and 6 minutes after IF 
perchlorate injected at 4s 8 and 20 minutes after 
IV
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discharge was 9*5 4 5.7 per cent dose.
Fall in ETA of between 10 and 20 minutes after radionuclide 
administration in 25 control patients was 0,12 0.25 per cent dose
(mean j; 18D),
Animal,Gtudy
Effect of IV Perchlorate on Thyroidal ^^1 Content Results arc 
summarised in Figure 38* IF perchlorate 4 minutes after IF 
reduced mean tî^rcid uptake of by 58^ from 0,186 j* 0,08 to 
0,115 + 0,057 fraction dose/g (mean + 18D), This result was highly 
significant (0,02 ^ P ^ O . O l )  using the paired »t* test. When 
perchlorate was injected at 8 minutes, mean thyroid uptalte was reduced 
by 25$ from 0,25 0,176 + 0,04 fraction dose/g, This result
was significant (P » 0,05). With perchlorate injection at 20 minutes, 
mean thyroid uptake was reduced from 0,564 ^  0*10 to 0*50 + 0*08 
fraction dooe/g* This result was not statistically significant 
(0.2 ^ 0 . 1 )  but was in keeping with the .previous findings*
Oontrol studies
When both tliyroicl lobes wore removed simultaneousiy in each of 
4 rats at 4, 8 and 20 minutes after injection, there was no 
difference between the mean uptalce of (i), 0,258 j; 0*72 and (R) lobe, 
0,25 j; 0,05 fraction dose/g (mean + ISD), In addition# whoa (b) 
lobe was removed 4 minutes after XV the mean uptake# 0,142 ^  
0,Qif2 fraction dose/g (mean ^  18D)# was significantly lower than the 
(B) lobe uptake at 10 minutes# 0.185 0,061 fraction dose/g
(0,05 ^  p ^  0,025)# if no perchlorate was given# indicating that
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partial t!:y.roldeotoRy did not affect function of the remaining lobe* 
These control results confirm the validity of the procedure.
DISCUSSION
In the last 20 years, there have been conflicting views on whether
iodide transport or organification provide the rate-limiting factor
for hormone synthesis in human thyroid. Despite elegant in vivo
studies by In^ar and Frienkel (1958), De Groot and Davis (1961) and
Nagataki and Ingbar (1965) which confirmed that rat thyroid accumulated
in excess of organification, there have been no directly comparable
studies to indicate that iodide organification is rate-limiting in
humans. Using a perchlorate discharge test conceptually similar to
that for humans, this in vivo animal study has confirmed the earlier
observations, firstly that unorganified (dischargeable) thyroidal
is present in rat thyroid, and secondly, that the amount present
decreases with time probably in parallel with a falling plasma
concentration* If these findings in rats are extrapolated to
os advocated by Ingbar @md Frienkel (1958), the human subjects with
normal Iodide organification should have discharged 20 - 25^ of
thyroidal content at 10 minutes (i.e. a mean of 0*75?^  dose in
normal subjects and a mean of 5% dose in thyrotoxic subjects).
Since no such discharge was demonstrated, the overall data clearly
suggests that iodide organification is less efficient in rats than
131humans and indeed, that organification of transported ^ i le 
virtually instantaneous in humans with a of approximately unity, 
a view previously championed by Berson and Yalow (1955) and Vanderlaan
94
(1957)# One can only presume that unorg^mified thyroidal iodlcle-127 
detected in human thyroid by chemical analysis (Ingbar, 1955) forms 
part of the functionally distinct second iodide pool (Halmi and Pitt 
Rivers, 1962) or is an artefact due to in vitro deiodination*
Though of proven value in detection of major defects of iodide 
organification (Fraser et al, I960), the conventional oral perchlorate 
discMrgo test is insensitive when the defect is minor* There are 
probably two main reasons for this limitation of the standard test.
Firstly, since thyroid content of must be quantitated for 
up to 40 minutes after perchlorate administration, each measurement 
of total neck uptake of requires individual correction for the 
contribution to it of ETA* This correction for ETA has usually been 
made indirectly (Fraser et el, i960) and is not precise* Secondly, 
percîilorato is administered one or two hours after oral (Fraser 
et al, I960; Floyd et al, I960; Baschieri et al, 1963) at a time 
when thyroidal ^^X-iodide content is falling in parallel with the 
plasma level* Stewart and Murray (1966) recognised the 
importance of early perchlorate administration though delayed this 
till one hour after oral ^^^I* Workers recently demonstrated that 
the clinioal value of a conventional oral test for detection of 
Haohlrnoto’s disease is enhanced by combining the oral dose of ^^^X 
with carrier iodide (Takeuchi et al., 1970)* It is problematical 
whether this expedient unmasks a true iodide organification defect 
or merely indicates undue susceptibility of iodide organification in 
Hashimoto’s disease to an increase in trapped iodide*
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Rosults of the djQiravonous perchlorate test in normal mid 
untreated thyrotoxiq patients indicate that fall in total neck radio­
activity (tîiyroid + ETA) immediately following perchlorate is related
131
primarily to fall in ETA of I. This is suggestive but not 
conclusive evidence for absence of unorganifiod ^^^I-iodide in glands 
with normal iodide organification. In contrast, patients with 
Hashimoto’s disease all demonstrated a fall in neck radioactivity of 
more than 0.5 per cent dose following perchlorate# Clearly this 
indicates a doorcase in thyroidal in addition to a fall in 
ETA and confirms that an iodide organification defect is a feature of 
Hasiiimoto*s disease* It also suggests that the intravenous test is 
more sensitive than the oral test since Mlson and Berne (1964), 
Buolianan et al (1965) and Volpe et al (I965 ) reported that the oral 
perclfLorate test was positive in on3y 50 - 50 per cent of patients 
with Hashimoto*s disease* A detailed comparison between tests will 
be required to confirm tliis. As expected, all patients with 
Pendred*s syndrome discharged a large percentage of administered dose, 
It is surprising, however, that no tliyrotoxic patients demonstrated a 
positive test ©specially as 5 had positive anti-thyroid antibodies 
which presumably indicated the presence of thyroiditis*
As perchlorate discharge in the human control group was 0.11 +
0.15 per cent dose (mean + 13D), a discharge of 0*11 + 5SD has been 
accepted as the upper limit of normality, i.e. a discliarge of 0*5 per 
cent dose* Discharge data has been presented as percentage of 
administered dose rather than percentage of thyroid uptake for two
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reasons, Firstly, aclmov/ledging random errors in the technique,
false positives are less likely with this approach since the error
associated with ETA measurement 1ms been eliminated* Secondly, had
the results been expressed as percentage of thyroid uptalte discharged, 
131quantitation of I Elf A with its inîierent error would bo necessary*
This ETA measurement would require administration of an additional 
131
25 uCi I and the complote test would take 20 minutes longer to 
perform*
In conclusion this simple teclmique appears to allow detection 
of both major and minor iodide organification defects and should be 
of practical value in a busy Department of Nuclear Medicine* In 
subsequent chapters, the author reports findings from the use of this 
test in a variety of thyroid disorders*
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GllAPSm 11 - SUMMARY
In a new approach to In vivo detection of defective iodide 
organification in thyroid, eodinm perchlorate has been injected 
intravenouelyi 10 mlnntea after intravenoue ^^^I*.iodide, to allow 
rapid performance of a perchlorate discharge test. Application of 
this test to normal and thyrotoxic patients has indicated that 
nnorganified iodide cannot be detected in thyroid glands where iodide 
organification is normal. In contrast, detection of moderate amounts 
of nnorganified iodide in normal rat thyroid by a similar discharge 
technique indicates a basic difference in thyroidal iodide metabolism 
between the species. The results imply that whereas iodide transport 
is the rate-limiting factor for normal hormone synthesis In humans ^ 
iodide organification is rate-limiting in rats. Where thyroidal 
Iodide organification is defective in humans as a result of disease, 
the test has been shown to be a simple and efficient method of 
detecting the abnormality.
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OHAmS 3.2
OKGANIFIQATIQN BATE OF THYEOXDAL 
IWIOAOTIVE IODIDE-131 i MEA^Dm'mNT IN VIVO
In this chapter, a method is developed for in vivo measuiement 
of the conversion rate of thyroidal radioactive iodide-131 to organically 
bound iodine-131,
INTRODUCTION
In Chapter 11, a simple technique for detection of inorganic
thyroidal radioactive iodide-131 was presented. To enhance
test sensitivity the results of this perchlorate test were expressed
131as per cent administered I discharged from thyroid. Since the 
fraction of total thyroid ^^^1 uptake which discharges is not measured, 
however, the test is purely qualitative* Quantitation of iodide 
organification requires measurement of the thyroidal organification
Workers have measured in vivo using complicated analytic 
techniques (Berson and Yalow, 1935; Xngbar, 1955; Robertson et al,
1971) but results have been conflicting. The author has concluded 
from two pieces of evidence documented in this thesis that there is 
little, if any, inorganic iodide in thyroid glands of normal and 
untreated thyrotoxic patients. Firstly, no ^ I was dischargeable 
from thyroid in normal and thyrotoxic patienta using the perchlorate 
test although a similarly conceived technique provided evidence for 
inorganic in normal rat thyroid (Chapter 11). Secondly, the
99
131
undoubted equivalence of thyroid net and unidirectional I elearancta 
(Chapter 8) make the presence of an unorganified iodide pool in thyroid, 
extremely unlikely* Since this argues that a defect of iodide 
organification is always associated with the presence of inorganic 
thyroid iodide, was measured only In those patients who demonstrated 
a perchlorate discharge of thyroid and it has been assumed that 
is near unity in glands where iodide organification is normal*
The proposed analysis is more simple than in any previous woxk 
and requires only the data from an intravenous perchlorate discharge 
test.
METHOD
The method is based on the following assumption^ regarding thyroid 
metabolism of iodide*
(a) Perchlorate completely blocks iodide transport
This assumption is based on the following observations*
1. When 30 - 230 mg of sodium perchlorate is injected 
Intravenously, and one minute later, is injected by 
the same route, measurement of neck radioactivity with 
directional counting reveals a gradual reduction in 
radioactivity over 20 minutes*
2. An identical pattern of falling neck radioactivity is seen 
in athyreotic patients (Oray, 1973) when is injected 
without prior perchlorate.
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(b) Where defective iodidQ QrganificutiQn J.s present in human
thyroid, g three compartment model (Chapter 4) accurately
131
portrays thyroidal ^ I kinetics
The validity of this assumption is based on the pioneer 
work of Wollman and Reed (1962a) in rata#
(c) Keok extrathyroidaX radioactivity (ETA) at 10 minutes is
administered dose 
For validity see Chapter 5*
(d) Perchlorate acutely reduces to gero in patiepts with 
defective iodide prganifiGation
Evidence in support of this can be marshalled as follows. 
When perchlorate blocks thyroid iodide transport, Inorganic 
iodide in thyroid may theoretically diffuse to plasma via K*^p 
and/or be organified via K^* Without making assumptions on 
the effect of perchlorate on K^, it can be proven mathematically 
(Appendix 3) suid demonstrated with analogue computation (Gray, 
1973) that the observed exit-rate constant for iodide, calculated 
from the observed perchlorate discharge curve, is the sum of the 
actual exit-rate constant and the organification rate constant, 
(observed) » (actual) +
Since thyroid ^^“^ c remains unorganified, the observed for
is always the actual K'^p and this measurement can be 
regarded as a base-line diffusion rate for any particular 
patient. When K*^p is measured, it is clear that the 
observed value will be greater than the actual value if is
0  6
05
0 4-
0 1
•  carbimazole 
0 partial defects
030 201
131I Kjp min:_-1
ICigiixa 39 8 This figure shows the correlation "between of
99m 1To and " I measured ‘Jja 8 patients with pmrtlal 
defects of iodide organifIcation (open circles), 
Buperimposed, on the same correlation from thyrotoxic 
patients on carbimazole (closed c5.roles « see Figure 20), 
Statistical analysis confirms tliat both sets of data 
could be drawn from the same population.
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the
unaffected by perchlorate and that/total discharge of tlnyroid 
iodide will not represent the original amount of thyroidal 
iodide present when perchlorate was given in this situation.
The present studies however liave revealed
(a) that in thyrotoxic patients currently on carbimazole therapy 
where may be assumed zero, for and showed
direct proportionality with the value approximately equal
to 2'J X ■^^ 1^ value (Figure 20, Chapter 8). The gradient mean 
j; 18D was 2*56 j; 1*25*
(b) Further, that in patients with partial defects of iodide 
organification where of was 1#9 x
value (Figure 39)* The gradient mean + 18D was 1,3 j; 0*63*
Since thoro is no statistical difference between gradients observed
in both groups of patients, the author submits tlmt perchlorate
administration in palients with partial defects of iodido organification
considerably reduces the efficiency of an already compromised
131organification mechanism. It is therefore lilcely that I discharged
from thyroid by perchlorate approximates to the total eumount of inorganic 
n the
present isi/gland when perclilorate is administered.
This hypothesis is not difficult to reconcile with the observation
of Do Qroot and Buhler (1971) that prolonged perchlorate administration
did not interfere appreciably with re-organification of second-pool
iodide. It is probable tliat perchlorate induces significant
inhibition of iodide organification only when is already compromised
by disease* A modest reduction in normal would hardly prevent the
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aoknowleâged slower organification of second-pool iodide documented 
by De Greet, Indeed Greer et al (1966) have produced convincing 
evidence that perchlorate can inhibit iodide organification in normal 
rat thyroid where, as the author has shown (Chapter 11), is 1.
It would appear like3y that a defective iodide organification mechanism 
in humans is more sensitive than normal to perchlorate thus providing 
a less than tenuous explanation for the author*» findings,
KINETIC MAIYSIS 
From the three-compartment model of thyroid iodide metabolism
where
B • organified thyroidal (fract, dose)
P « unorganified thyroidal ^^^I (fract, dose)
organification rate constant (min*'^ )
/ti
/ 0
Reorganising this equation and differentiating,
(ti)»
To obtain from an intravenous perchlorate test therefore, both 
rate of change of organified thyroidal ^ ^^I (B) at 10 minutes and 
quantity of unorganified thyroidal (F) at this time are required,
F can be measured frcas the drop in thyroid radioactivity after perchlorate. 
Assuming ETA at 10 minutes, total thyroidal at 10 minutes can be 
measured and subtracting F, organified thyroidal ^^^I (B) can be 
calculated. Solution to the final problem of calculating dB/dt at
LU
o
o
zo
§
ÛC
LU B2
B3
i
o
ÛC
>-
SE
F2
105
TIME (minsJ
151Fi/jiiro 40* ExaaiplQB of pairs of thyroidal I uptalce curves
produced hy the arialo^ 'ue computer representing
orgojiified (b) and inorganic (P) over a 10
151minuto period after I? I injection. For 
préparation of the tîiree pairs of curves displayed, 
unidirectional clearance (c) and exit-rate constant 
vrero held oonst&mt and the organification-rate 
constant (K^^) was varied. was O.40 for curves
P^/b^, 0.25 for Fg/Bg and 0.10 for P^/B^.
Tangent^
(b)
Tangent^
Tangent^
10-2
TIME (min.)
Figure 41s Paire of tîo^oidal organified (B) and inorganio (?) 
151I ourvee over 10 mimitee post TV injection as 
portrayed by tho analogue computer. Y/hen F B at 
10 minutes (a), the tangent to B ouwe at 10 minutes 
intercepted time axis at approximately -h 2 minutes. 
Y/hen 4?^ B ^  ? at 10 minutes (b), the tangent to B 
curve at 10 minutes intercepted tirae axis at 
approximately aero minutes. Vlien B ^  4? and 
^ 0.40, the tangent to B curve at 10 minutes 
intercepted time axis a,t approximately «• 2 minutes.
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10 minutes was indicated by studies with an analogue computer*
Calculation of dB/dt (10 min)
Simulation of a three-compartment thyroid model with analogue 
computation (Appendix 2), edlowed production of pairs of thyroidal 
uptake curves « representing organified (B) and unorganified (P) 
content with time* In this study* various plasma decay 
curves were used and each of the three rate constants of the model 
(C* K^pt were varied. Examples are shown in Figure 40, The 
following were observed from curves produced.
1* A predictable effect of rise in was an increase in both 
rate of rise of B curve and rate of fall of F curve*
2* The B curve# integral of F x K^* was virtually a straight line 
for 0,10. With 0 * 1 0 < ^ K ^ < ^  0,40, the B curve was a
straight line from the simulated 7th minute onwards# 
dB/dt at 10 minutes is clearly obtained from measurement of the slope 
of the B curve at that time. It was found that
1, when F ^  B at 10 minutes, the 10 minute tangent to B curve 
intercepted time axis at approximately 2 minutes (Figure 4la),
2, When 4F ^  B ^ F  at 10 minutes, the tangent to B curve intercepted 
time axis at approximately ssero minutes (Figure 4lB),
3, When B ^  4f at 10 minutes, the 10 minute tangent to B curve 
intercepted time axis at approximately minus 2 minutes up to a
of approximately 0,40 (Figure 4lc),
Being this information, a reasonable approximation to dB/dt at 10 minutes 
could be obtained as follows*
î
_100
o
60
2 0
010 0 20 030 0 40
K j b  ( m i n “ ^)
FlGVTO 42î œiiia graph ehows the non-llnear rolationehlp between 
the ovgeni
151
r ification-rate oonetant of thyroidal
inorgenic and the percentage of tl'^oid uptake 
discharged at 10 minutes by perchlorate* The graph 
was constructed using the eg^ uations developed *Ui this 
thesis*
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(a) When B, (dB/dt) at 10 min = LSl..i|S„,glaA
(b) When (dB/dt) at 10 win .
(c) When B ^ 4 f , (dB/dt) at 10 min for K ^ ^ O , 4 o
With the above approximations and by studying many pairs of F and 
B curves produced on the analogue computer using varied plasma 
curves and variable and the author found that:
(i) Variation In plasma curve and constant C had no effect 
on dB/dt approximation^ K^p and being constant,
(ii) Though large values^ 0,15 were an increasing source of
error in dB/dt approximation# variation in the physiological
range 0,Q5 to 0,12 (Chapter 8) had little effect,
(iii) Brror of dB/dt estimation using the chord approximation with 
0,05^^ 0*12 was a maximum of 13^ provided 0,40,
When increased beyond 0,40# the error became unacceptabîy 
large.
It appeared therefore# that us^ lng the intravenous perchlorate test 
with perchlorate injection at 10 minutes# one can predict that:
(») whân B, Kjjg - ^
(b) whMi
(e) when 4f ana 0.40, ^
Using these equations, the approximate relationship between
131
and perchlorate discharge of unorganified thyroidal 1 as a perceni 
of total thyroidal uptake# may be portrayed (Figure 42), This
I
%
§
I
H
•M
V D
f—I
■M
•4"
oo
oj
r\
1^
c>-
CO
I
H
Ih
I
I
ftI
H
i
a
B4
I
g
e
o ao
• Î - I
K)
o
&
o
1^
ao
IT\
H r \ lA
II II 11
PI pt Pi
+>
m
0> Q
m fl) 04
d a fe»0) o t A
d
*H rd W H
PI 'H  Û)
R, W
W (0 o  +>
O
o w •fi S+J r4 q
o O 'H
<y ■P -P
O 01
'd 0  -H
m Pi
c6 <D ,Cl 0
Ph E-1 P)
I
I
a
r4
I
0
1
n3
I
0 40
0 35
030-
010
CO
H
'sL 0 05
4 6 8 10
P B 1 2 7 ,  ( p g % )
12
Figure This figure shows the poor correlation (r - 0,35)
obtained between thyroid status as measured by a 
^127j the thyroidal organification~rate
constant C^^)* Subjects studied were 13 patients 
with Hashimoto*s disease, 3 patients following 
radioactive iodine treatment for thyrotoxicosis 
and 3 patients with Pendred*s syndrome.
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graph eliminates the necessity for separate ealeulation in each patient
studied and requires only that tho fraction of total thyroid uptake of
which is discharged at 10 minutes is known.
PATimns m m iED AND psooedmb
Of 33 patients studied* 13 had clinical evidence of HasMmoto’s
disease (goitre and strongly positive tests for serum anti^thyroid
antibodies)* 3 had received a therapy dose of radioiodine (^^^I or
1 3 3 for thyrotoxicosis 4 8 months prior to test* and 3 had peadred«s
syndrome* In each patient* an intravenous perchlorate test was
performed (Chapter 11) though the test was terminated only when
thyroidal discharge iiad ceased* Total thyroidal radioactivity
at 10 minutes was calculated by subtracting ^  dose (approximate ISTA)
from total neck uptake at that time* Overall thyroid status was 
127assessed by a M5 I measurement* for each patient was obtained
from Figure 42* using the pei'centage of total thyroidal uptake of 
discharged by perchlorate.
m B W S B
The results are summarised in Table 8 and portrayed graphically 
in Figure 43# A poor correlation (r » 0*33) between and
p^l37^ was seen in the group of patients studied*
m^omaioN
The method presented for approximation of has the virtue
of technical simplicity over other techniques (Berson and Yalow, 1933î 
ingbar* 1933î Robertson et al* 1971)* A poor correlation between
and FB indicates that measurement is of limited value as 
an index of total thyroid function* This is hardly surprising since 
a radioactive rate constant allows a meaningful comparison between 
subjects only when the stable pool (in this case, inorganic tliyroid 
iodide) to which it pertains is either known or is of comparable siae 
in different subjects* Clinical usefulness of measurement is 
clearly limited by variation in siase of the thyroid inorganic iodide 
pool between patients with different thyroid pathologies and between 
different patients with the same thyroid pathology* Its measurement 
could theoretically be useful for sequential analysis in the same 
patient where the iodide pool might be expected to remain constant*
This possibility has been explored in Chapter 14.
It is interesting that the relationship between fraction of 
thyroid uptake discharged and is non-linear (Figure 42). There 
would appear little merit therefore, in the time-honoured presentation 
of perchlorate test data as fraction of thyroid uptake discharged, since 
approximation requires knowledge of this graph. This fact, coupled 
with the unsatisfactory correlation of with thyroid status,
argues for presentation of intravenous perchlorate test data as 
percentage administered dose discharged* Although the test will 
thereby remain purely qualitative, sensitivity is clearly enhanced by 
this approach*
In conclusion, measurement of ^^^I has little place in clinical
127
investigation and until it is possible to quantitate I an 
intravenous perchlorate test per se is the most appropriate procedure 
for assessment of thyroid iodide organification*
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- QMCTR. 12
A simple theoretical analysis has been developed for quantitation
of thyroidal iodide organification* Extensive use of analogue
computation peiwitted formulation of basic equations which defined
organification rate of ^^^1, in terms of the fraction of total
thyroidal content at 10 minutes which is discharged by perchlorate.
The calculated correlated poorly with thyroid status
127
(PB I), presumably because of inter-patient variation in sise of the 
stable thyroid iodide pool. It was tentatively suggested that 
measurement could be useful for sequential analysis of iodide 
organification in individual patients.
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C M m R  13
HASHIMOTO*Q DISBABEg . IT0 DIFFERENTIATION FROM 
SBîPIÆi G OZm . USING THB mMVBNOUS 
PERCIILOmTE DISCHARGE TEST
Di this chapter, the intravenous perchlorate discharge test is 
applied to the differential diagnosis of non-toxic goitre, and a role 
for this test in the definitive diagnosis of Hashiaoto’s disease is 
proposed.
imjRODUQTXON
Differentiation of Hashimoto's disease from simple goitre on 
purely clinical grounds is often difficult when the patient is 
euthyroid* Routine thyroid function tests may also be equivocal in 
both conditions (Murray and McGirr, I960; Buchanan et al, 1963{
Shane et al, 1963) and although high titres of serum anti-thyroid 
antibodies are diagnostic of Hashimoto's disease (Eoitt and Doniaoh, 
1958), low titres are not, since these are found in 20 - 3pg6 of 
patients with simple goitre (Doniaoh et al, I960). Needle biopsy of 
thyroid appears to be the most definitive diagnostic technique (Beahrs 
et al, 1962; Heimann and Schnurer, 1964) but despite a negligible 
morbidity associated with its use, popularity for the procedure varies 
from centre to centre (Williams, 1968).
The intravenous perchlorate discharge test was used to study 112 
patients who presented with non-toxic goitre. The author»s aim was 
to determine whether the defective thyroid organification of iodide.
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found in Hashimoto*s diBeaoe (Chapter 11) could allow its accurate
differentiation from simple goitre* The author’s experience with
the test, the results and their diagnostic utility are discussed,
MATERIALS AND METHOD
Patients Studied and Criteria Adopted
A total of 112 patiente were studied. All attended the Thyroid
Clinic at the Royal Infirmary, Glasgow with a non-toxic goitre larger
than a clim.cally estimated 40 g. Patients with suspected carcinoma
of thyroid wore not included isi the study.
An ultimate diagnosis of Hashimoto’s disease was made in a total
of 33 patients. This diagnosis was confirmed in 22 by histological
examination after thyroidectomy (16) or needle biopsy of thyroid (6),
In the renWning 31 patients, diagnosis of Hashimoto’s disease was
made because they were either liypotliyroid with positive tests for
serum anti-thyroid antibodies (26) or euthyroid with strongly positive
tests for these antibodies (3)#
An ultimate diagnosis of simple goitre was made in a total of 40
patients. This diagnosis was confirmed in 10 by histological
examination after thyroidectomy. In the rejnaining 30 patients,
diagnosis of simple goitre was made because they were euthyroid with
131negative tests for serum anti-thyroid antibodies and had a PB I 
0.2^ dose/litre at 48 hours.
Of 112 patients studied, 19 were not included in the results. 
These were;
1, Ten patients in whom data collection was incomplete.
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2, 5V/0 euthyroid patients with negative antibody teste but a
.131
3 >  0*3»PB" I >  0.3K dose
3# Five euthyroid patients with low titres of anti-thyroid antibodies 
in whom a biopsy was not obtained*
4. Tvïo patients with different diseases* One had amyloid goitre, 
the other Eiedels thyroiditis*
Imnrunological Studies
Preotpitating antl-thyroglobulin auto-antibodies were detected 
by the Ouohterlony plate technique (Anderson et al, 1962), Anti- 
thyroglobulin was detected by the tanned red cell haemagglutination 
test described by Fulthorpe et al (1961) using thyroglobulin-coated 
formoliesed tanned sheep red cells (Burroughs Wellcome),
Anti-microsomal auto-antibody was measured using an immuno- 
fluoreecent technique (Holborow et al, 1959)*
Patients were considered to have high titres of antibodies when 
the precipitin test was positive and/or GF test was strongly positive
and low titres when TEG was <C% 3/3 to 1/250 and/or OF test was weakly
positive*
Studies of Iodine Metabolism
Measurement of 48 hour was performed as described by
Wayne et al, (1964)# Thyroid status was confirmed by either a
or total serum thyroxine measurement usdng the Thyopac-4 kit
(Radiochemical Centre, Amersham), The intravenous perchlorate test 
was performed as previously described (Chapter 11),
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Figure 44s Tho résulta of the TV perchlorate clischarge teat in 
53 patients with Hashimoto’a disease* Group*a* 
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PvOsuXts of the perchlorate teet in the ^ 3 patients with
ïleGhimoto^s disease are shown in Figure 44# 'Twenty«‘two patients
in whom histological proof of diagnosis was obtained dieoharged
a*04 ^ l*l4% dose (moan ^  ISD) while 31 patients in whom the diagnosis
appeared to be Hashimoto^ disease with a high degree of probability
discharged 2#?8 ± 1*9% dose (mean + ISP)*
Results of tho perchlorate test in the 40 patients with simple
goitre are shown in Figure 45* tCen patients in whom histological
proof of diagnosis was obtained discîiarged 0*51 ^ 0*51% dose (mean ^
ISD) while 30 patients judged lil:ely to have a simple goitre discharged
0*51 ± 0*35% doso (mean ^  ISD)* îhe dlfferonco between Ilashimoto
and simple goitre groups as a whole, was highly significant (p <^*001)*
The degree of discrimination obtained between Hashlmoto*o disease
and simple goitre using the perchlorate test alone is shown in Table 9* 
the V.
With/standard criterion for a positive test (discharge 0*55^^^ dose)
an average of 95% of patients with Hashimoto*s disease and 45% with
simple goitre showed a positive test# When the criterion for test
positivity was revised to 1*0% dose discharge* an average of 80%
of patients with Hashimoto^o disease but only 11*5% with simple
goitre showed a positive test*
Data on 5 euthyroid patients with low titres of serum anti-thyroid
antibodies where the clinical diagnosis was obscure is shown in Table
10* The perchlorate test correctly categorised each patient before
thyroidectomy. Also documented arc 2 euthyroid patients with negative
1X2 "•
tests for serum anti-thyroid antibodies* The perchlorate test led 
to an incorrect diagnosis in 1 of those patients*
pigcïïssioM
The incidence of positive oral perchlorate discharge tests in 
Hashiraoto’s disease lias varied considerably in all series reported 
in tho literature* Although Morgans and Trotter (1957) and Murray 
and IIcGirr (I960) each found the test 100% positive in a small series 
of patients, Hilson and Berne (1964), Buclman et al (1965) and Volpe 
et al (1965) who studied larger numbers of patients found only 48%, 
30?^ and 30% positive tests respectivoXy* The author’s finding of a 
high incidence of positive IV perchlorate tests in patients with 
Eaehimoto^o disease would appear to confirm the uniform presence of 
defective utilisation of trapped iodide in this condition and indeed 
suggests tloat tho IV test is more sensitive than the oral test* A 
further detailed comparison between techniques will be required to 
confirm this* It is likely however that the IV perchlorate test is 
the most discriminant of all radioactive iodine tests of thyroid 
function for diagnosis of Hashimoto’s disease since other tests so 
often produce variable and conflicting results (Dastenie and Brmans,
1972).
It is of interest that the IV perchlorate test gave evidence of 
defective organification of thyroidal iodide in 19 out of 40 patients 
with simple goitre. Although this minor degree of dyshormonogenesis 
in simple goitre has been previously documented In vivo (Morgans and 
Trotter, 1957s Baschieri et al, 1965) and in vitro (Dimitriadou et
113 -
al, i960) ,it remaiîajB problomatical whether simple goitre develops 
because iodide organification is defective or whether tho defect 
appears after goitre forimtion# It is unlikely that this defective 
iodide organification in patients with simple goitre could be 
explained by areas of focal tliyroiditis (Buchanan et al, 1965) because 
serum antibody tests were negative* Indeed, it is debatable whether 
focal thyroiditis is causally related to defective iodide organification 
at all since none of the thyrotoxic patients previously studied (Clmpter 
11) showed a positive test despite the presence of high titres of serum 
anti-thyroid antibodies*
Considering the IV perchlorate test in isolation, it is clear 
that useful discrimination between Hashimoto’s disease and simple goitre 
may be obtained by using 1*0% dose discharge as the ’significant^ level 
rather than the experimentally derived normal discharge of 0*5% close 
(Table 9)* By this expedient, 80% of patients with Hashimoto’e 
disease were positive but only 11*5/^  in the simple goitre group* 
Although this degree of separation between diseases is similar to that 
obtained using serum anti-thyroid antibodies in isolation (Doniach et 
al, i960), it must be remembered that, whereas high titres of anti- 
thyroid antibodies in a euthyroid patient with a goitre are diagnostic 
of Hashlmoto’s disease, a discharge of ^  1*0% dose can only imply 
the diagnosis of îiashimoto’s disease since this functional abnormality 
could be the result of a number of separate congenital and acquired 
thyroid conditions*
Host clinicians will concede that diagnosis of Hashimoto’s disease
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cmi be made with confidence in euthyroid patients with non-toxic 
goitre when high titres of serum anti-thyroid antibodies are detected 
or when îiypotlîyroidiem is associated with the presence of medium or 
low titres. The problem in clinical practice arises when euthyroid 
patients with underlying thyroiditis iiave low titres of antibodies 
since differentiation from simple goitre may be difficult unless a 
thyroid biopsy is performed. It is lilzely that approximately 3 %  
of patients with simple goitre and 10 - 2Q% patients with Hasiiimoto’o 
disease fall into this category (Hall, 1962). In this study, a 
histological diagnosis was obtained in 5 such cases and in each 
subject, the IV perchlorate test predicted the correct diagnosis 
prior to thyroidectomy (Table 10), Accordingly, it is anticipated 
that the role of the IV perchlorate tost in investigation of non-toxic 
goitre will be as an adjunct to diagnosis in euthyroid patients with 
low titres of anti-thyroid antibodies, Gince the IV test incorrectly 
predicted the diagnosis in one of the two euthyroid patients with 
negative antibodies who discharged 1.0% dose, its precise role 
among these patients requires further clarification.
It would appear that by combining thyroid status, serum anti­
thyroid antibody titres and the IV perchlorate test, a high degree 
of precision in diagnosis of Hashimoto’s disease from simple goitre 
will be obtained which should obviate the need for thyroid biopsy in 
most cases. Biopsy remains mandatory if carcinoma of the thyroid is 
suspected in addition to Hashimoto’a disease (Ghands, 1960$ cheeky 
et al, 1962). One patient with Hashimoto’a disease who discharged
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3,0% dose, had a co-existent carcinoma. Clearly a high index of 
suspicion is of paramount importance for tliis diagnosis.
In conclusion, the iiitravenous perchlorate tost has a role in 
the definitive diagnosis of Hasklmoto’s disease and will he a useful 
adjunct in the differential diagnosis of non-toxic goitre.
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SUMMARY - . CHAPTER 1%
In a study of patiente with non-toxic goitre* the intravenous 
perchlorate discharge test indicated the presence of defective 
organification of thyroidal iodide in nearly all patiente with 
Haehimoto’s disease but in less than half those with simple goitre* 
Improved diagnostic discrimination was obtained by setting limits of 
significant discharge to at least 1% of administered ^^^1 dose.
Using this criterion, 80% of patients with Hashimoto’s disease but 
only 1%^ of patients with simple goitre showed a positive test*
The intravenous perchlorate discharge test would appear of most value 
in clinical practice for the differential diagnosis of non-toxic 
goitre in those euthyroid patients who have low titres of serum anti­
thyroid antibodies*
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DEFECTIVE lODIUB QRGAMIPIQATION IN TIÏYHOXD 
FOLlOWlia THERAPEUTIC IRRADIATION: WITH 
RADIOACTIVE IQUIUE-131 OR 125
This chapter describes an in vivo study of iodide organification
in tliyroid following radioactive iodine therapy for thyrotoxicosis.
The significance of the findings and their relevance to concepts of 
125I riiicrodosimetry are discussed.
IiMTROUUCTIOU
Although many workers have diligently studied the therapeutic
uses of radioactive iodine-131 little attention has been
devoted to disorders of thyroid physiology following such treatment*
As described in Chapter 10, most in vivo studies of tliyroid function
after therapy have involved quantitation of thyroidal iodide transport
151by the teolmically simple measurement of early thyroidal I uptalce*
A few researchers have studied thyroidal iodide organification in 
vivo after ^^^I therapy (Kirklandj 1954? Larson, 1955? Keiffer et 
al, 1965) and have confirmed tliat defects of this mechanism can be 
radiation induced, but they provide conflicting evidence on both 
incidence and likely effect of the defect on the outcome of treatment* 
In Chapter 10, it was proposed that a tliyroid uptalce of 
could be used after therapy for sequential assessment of thyroid 
function* Since defects of iodide handling reduce the reliability 
of measurement of iodide transport (i*e* uptalce) as an
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index of total thyroid function, knowledge of the efficiency of this
second step in hormone synthesis is clearly essential when ^^^Tc is
used in this way. Accordingly, the intravenous perchlorate discharge
test has been used to study this particular aspect of post-irradiation
hormone synthesis.
Aims of the pilot study were twofold. Firstly, to assess the
151probable incidence of iodide organification defects following I 
125and I therapy. Secondly, to determine whether the radiobiological
effect on thyroidal iodide organification was dependent on the micro-
dosimetry of the particular radionuclide used for treatment.
IMi-lRIALS. AMD milOD.
Twenty seven patients were studied and in all, the clinical
diagnosis of tliyrotoxicosis was confirmed by routine radioactive
127iodjuio thyroid function tests and a KB I. All patients were treated 
as out-patients and each had diffuse tliyroid enlargement with an 
approximate thyroid weight of between 25 and 75 g# Twelve patients, 
all female, vdiose ages ranged firom 36 to 55 years (45 j: 7 years =* 
mean ^  iSh) were given thirteen therapy doses of I (6*4 ± mCi = 
mean 1333 )* Fifteen patients J 2 male and I5 female, vdiose ages 
ranged from 39 to 62 years (46 + 6 years = mean j; ISU) were given 
fifteen therapy doses of (12*3 ± 4*4 raCi = mean 1* ISD). Thyroid 
function was measured with the intravenous perchlorate discharge test 
(chapter 11) and a EB‘ I before and regularly after treatment*
Data from treated patients was obtained retrospectively?
the study was prospective. In 6 patients treated with ^^^I
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MONTHS AFTER 125, THERAPY
X51
I'igmro 46: A serial calculation of the thyroidal X organification-
rate constant (l{^) in 6 patients who demonstrated a defect 
of iodide organification in thyroid after radioactive 
iodine-125 therapy for tliyrotoxioosio. When O.4O 
^  1.0, it Y/as arhitrarly placed on the graph at = O.6O.
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whore a defect of iodide organification Tfas detected on more than two
occasions, serial calculations of were made (chapter 12),
151It was assumed that secretion of organic I from thyroid during 
the perchlorate test was negligible.
RIÜSÏÏXÆS
gherapy.
Data is presented in Table 11, There was a positive discharge 
test in 5 of 9 patients studied (55'/^) between 6 and 12 weeks after 
therapy but only 1 of nine studied (l2i/o) between 15 and 24 weeks after 
therapy4 Between 25 » 56 and 57 - 40 weeks after therapy, positive 
tests were seen in 1 of 5 (35/0 and 2 out of 6 (55/0 patients studied 
respectively.
In 1 patient (number 4)» the defect of iodide organification has 
persisted for 18 months post therapy and she has remained euthyroid 
with a of approximately 846 ug/lOO ml for over a, year*
jPhsragg,
Data is presented in Table 12* In the first 4 weeks after 
therapy a weakly positive discharge was seen in 1 of 8 patients studied 
(l2‘/0l between 4 and 12 weeks* 7 out of 11 were positive (64/^ 01 
between 15 and 24 weeks, 9 out of I5 wore positive (60^0g between 
25 and 36 weeks* 5 out of 9 were positive (55*5>Ol and between 57 
and 48 weeks, 2 out of 6 were positive (550)*
A serial calculation of (Chapter 12) in 6 patients with 
persistently positive tests is shov/n in Figure 46* Only 1 case 
(number 5) was undoubtedly euthyroid when the study endedi Since
120
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calculation is accurate only up to a value of 0,40 rain , values
of 1.0^^^ 0,4 were placed between the interrupted,lines on
the figure at ?= 0,6 min"*^ . Two main features were firstly, the
!l 25general delay of some weeks after ' I therapy before fell and
secondly, a tendency for iodide organification to recover with time.
Statistical Analysis
The difference in incidence of defects of iodide organification 
151 125between the I and *” 1 treatment groups was statistically
significant only in the groups studied 13 - 24 weeks after therapy.
At this, time, 11,2 j; 10*5/^  (proportion h- SB of proportion) of patients 
treated with shov^ ed a defect and 60,0 ^  13,2;i (proportion ^  SB
of proportion) of patients treated with showed a defect* The
SE of difference between the groups was I6*8^ b. This observed 
difference xras approximately equal to 3 % its SB and P - «01,
DISCUSSION
131Data collected retrospectively from patients treated with I 
indicates that defects of tlyroidal iodide organification do not 
commonly occur following therapeutic use of this radionuclide. This 
is in agreement with the findin^ gs of Larson (1955) but conflicts with 
the report of Keiffer et al (I963)*
The more comprehensive dsla from the prospective study of 
patients treated with radioactive iodine-123 (^^^l), al.low some 
generalisations to be made*
1, The post-irradiation defect of iodide organification is uncommon 
in the first month after therapyi
Comparison of and
131 j 
COLLOID
Nuclear irradiation high 
Reproductive capacity 
reduced.
K 10 )j
Apical irradiation high 
Functional capacity 
reduced.
COLLOID
Figure 47î DiagraJiimatio repreoentation of the hypothetical micro- 
clooimetry of and across tliyrotoxio follicula
131cells* Whereas the penetrating electrons from I
irradiate both follicular cell cytoplasm end nucleus, 
' I tends to selectively irradiate the colloid-cell 
interfane where iodide organification occurs with a 
relative sparing of the cell nucleus*
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2> Thereafter, the defect is common and most often appears between 
1 and, months after therapy*
3'* There appears no consistent relationship between the presence of 
a defect and any particular tliyroid status# Surprisingly some 
patients remained clearly thyrotoxic despite a major defect of 
iodide organification.
Notwithstanding the small number of patients studied, it is clear 
125tl'iat I therapy is more likely to reduce the efficiency of thyroidal
13Diodide organification than treatment with an equivalent dose of 1.
This important observation will be seen to have theoretical and
125practical relevance to concepts of and rationale for, I therapy#
Nuclei of tliyroid follicular cells have been shown in vitro (Hall 
in
and Grand, 1962) and/vivo (Greig, I963) to be more radiosensitive than
those areas of cell where hormone synthesis occurs* The radiation
dose required to impair hormone synthesis will therefore tend to
create severe nuclear damage with resulting cell sterility or death.
131This sequence of events is the liicely prelude to post I therapy
hypothyroidism (Greig, 1963), and is thought to result from uniform
irradiation of thyroid cells and stroma from energetic B emissions of
(Figure 4?). In contrast, theoretical calculations (Gillespie
et al, 1970) have indicated that emitted electron radiations from 
1?5I have a low penetrating potential. The therapy dose will 
therefore exert a greater radiobiological effect on the apical margin 
of cell (Figure 47) and hormone synthesis than on the nucleus and
basal surface (iodide transport). Such theoretical considerations
125imply that the special microdosimetry of I will allow both
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satisfactory control of thyrotoxicosis and relative freedom from
subsequent thyroid failure because of a proportionate decrease in
nuclear damage. Confirmatory data on Ï microdosimetry has been
obtained from elegant animal studies (Gross et al, D.968; Greig et al,
1970), This observation that therapy reduces efficiency of
131iodide organification more commonly than I therapy extends such 
supportive data at a clinical level,
125A further interesting feature in the I treated patients is a 
delay of several weeks before this particular dyshormonogenesis is 
detected. This suggests that the phenomenon is related to total 
gland radiation rather than therapy dose-rate,
125These patients have been studied for up to 1 year after I 
therapy. Although the long term effect of this particular defect 
is conjectural, it would seem likely that those patients who develop 
major defects of iodide organification, will be more sensitive than 
noraial to further therapeutic irradiation*
When more data from treated patients is available, firmer 
conclusions on the relative incidence and therapeutic significance 
of defective iodide organification will be possible.
- 123 *“
SmmRY - CHAPTER 14
The intravenous perchlorate discharge test was performed in a
small series of thyrotoxic patients at intervals up to 1 year after
radioactive iodide-131 or -123 (^ *^ 1^) therapy, to define the
radiobiological effect of each radionuclide on thyroidal iodide
organification* Organification dyshormonogenesis was more commonly
125detected following I therapy and this difference between radio­
nuclides was highly significant between 3 - 6  months after therapy 
when 60;^  of patients given but only 11^ 6 of patients given
demonstrated the abnormality. These results are totally consistent
125with a current hypothesis on I raicrodosimetry in which it is 
believed that the apical membrane of thyroid follicular coll, site 
of iodide organification, receives more deposited radiation than the 
nucleus and basal cell membrane.
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CHAPTER 13
FAMILIAL GOITEOUS HYPOTHYROIDISM:
INVESTIGATION OF THREE SIBLINGS
This chapter presents an unexplained remission of hypothyroidism 
in one of three brothers who each had a defect of thyroidal iodide 
organification.
INTRODUCTION
A well documented clinical and biochemical diagnosis of hypo­
thyroidism is usually correctly accepted as indicating the need for 
life-long thyroxine therapy unless the patient has received a drug 
which is known to, interfere with tliyroxine synthesis* Such drugs 
include oarbiiiaaole, iodide (Begg and Hall, 1963), para-arninosalicylate 
(McGregor and Sommer, 1934) and resorcinol (Bull and Fraser, 1930)*
In these circumstances, withdrawal of the.offending drug results in 
a remission of hypothyroidism.
The author has had an opportunity.to study and here reports a 
remission of clinical and biochemical hypothyroidism which occurred 
in one of three brothers each of whom presented with goitrous hypo­
thyroidism.
CASE MATERIAL
Methods
Case 1 (G.B.) This patient presented to Dr. J.A. Thomson, Royal 
Infirmary, aged 19 years in I966. He was clinically liypothyroid 
with an enlarged thyroid gland x 2* Hypothyroidism was confirmed
Figure 43i Histology of thyroid in case 1. G.B. (x 560).
The follicular cells show ovidence of TSH stimulation 
but thyroiditis is not present.
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with a PB I of 0.3 ug^ and a BMR hT/o below standard. The thyroid 
uptalce at 4, 24 and 48 hours after oral was 17, 13 and 12?^  dose 
respectively and a 48 hour was negligible. The salivary :
plasma ratio of I was 16 ; 1 and a conventional oral perchlorate 
discharge test was negative. A thyroid biopsy showed a hyx^ erplastic 
gland without evidence of thyroiditis (Figure 48) and a precipitin 
test was negative. An oral MIT test revealed normal deiododination 
activity in body tissues thus excluding a dehalogenase defect in 
thyroid.
A diagnosis of probable dyshormonogenetic goitre was made, 
although he did not fit into any of the typical defect patterns, emd 
ttiyroxine therapy was instituted. On thyroxine, signs of hypo­
thyroidism disappeared and the tliyroid gland became impalpable.
In May, 1970, at the author's invitation, the patient agreed to 
discontinue tliyroxine to permit further study. Subsequent
investigations are shown in Table 13. One month after stopping
131tliyroxine, his early thyroid net clearance of I (Chapter 8) was
elevated and showed a 30/& reduction in the 15 - 20 minute period as
compared to the 3 - 10 minute period; this was consistent with the
presence of a defect of iodide organification (Owen et al, I960).
Reassessment at 20 and 46 weeks after stopping thyroxine revealed
131firstly, a reduction in absolute net clearance of I with continued 
evidence for defective iodide organification and, secondly, unequivocal 
eutliyroidism. At 46 weeks, the IV perchlorate test (chapter 11) 
confirmed defective iodide organification with a discharge of 1.6%
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dose. Similar results were obtained at l6 and 28 mouths after
127stopping thyroxine, his PB I remaining approximately 8.2 The
serum TSH, estimated at 28 months by courtesy of Professor Hall, 
Newcastle, was 2,1 u units/ml (normal range 0.3 - 3,3 u units/ml).
He remained asymptomatic but when reviewed 40 months after stopping 
thyroxine, tho intravenous perchlorate test revealed an increased 
discharge of 4.,9% administered dose. A total serum thyroxine of 
2.6 ug/100 ml, serum triiodothyronine of 1,9 ng/m3- and serum TSH of 
33 units/ml, all measured by Dr. Eatcliffe, Glasgow, confirmed that 
a relapse of hypothyroidism was imminent.
Case 2 (W.B.) This boy, brother of case number 1, presented to
Dr. M.J, Riddell, Victoria Infirmary, Glasgow in 3939, aged 11,
He was clinically hypothyroid with an enlarged thyroid gland % 2,
BMIÎ was 34% below standard and serum anti-thyroid antibodies
(precipitin test and CF teste) were negative* Thyroxine was
commenced but treatment lapsed the following year* In 1963, when
again clinically hypothyroid, he presented to Dr. J.A, Thomson, Royal
127Infirmary, Glasgow for investigation, PB I at this time was 0,1 ug^ a 
and a conventional oral perchlorate discharge test was negative* He 
was recommenced on thyroxine and soon became euthyroid.
In M^, 1970, like his brother, he agreed to discontinue tliyroxine 
to allow further study. Subsequent investigations are shown in Table 
14. Four wooks after stopping thyroxine, his thyroid net clearance 
of was in the high normal range and showed little reduction in 
the 5 « 20 minute period. Five montlis after stopping thyroxine.
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127however, he was clinically mildly hypothyroid with a FB 1 of
3.0 ug)o and a marked reduction in net clearance of was detected 
in the 3 20 minute period indicating defective Iodide organification,
Confirmation of this defect was obtained with the IV perchlorate test 
which demonstrated a discharge of 1.6% dose* Treatment was witliheld 
for a further 4 weeks but since hypothyroidism became more obvious 
clinically, thyroxine therapy was restarted.
Case 3 (E.B.) The third brother, aged 17 years, was first seen
in April, 1970 by Dr, M,J, Riddell, Victoria Infirmary, Glasgow when
he presented with goitrous hypothyroidism. On subsequent referral
to the Thyroid Clinic, Royal Infirmary, Glasgow for further
investigation, he was found clinically to be grossly hypotliyrold with
] ?7
a thyroid gland enlarged x 3. Although a PB ' I at this time was
3.0 ug% the 24 hour uptalce of ^^^I was l8% dose and PB^ '-^ I^was
negligible. Thyroid precipitin test was negative# Detailed
131investigations are shown in Table 13. The I clearance studies 
showed the classical pattern of defective iodide organification; 
high initial value and subsequent reduction* Thyroxine therapy was 
commenced with dramatic clinical improvement and disappearance of his 
goitre•
Seventeen months after commencing tliyroxine, treatment was
withheld for 6 weeks to allow further assessment* At the time of
127 131this study, PB I was 6.3 ug>,< and the I net clearance revealed
a 30% reduction over the period 3 ^ 20 minutes* An IV perchlorate
discharge test confirmed a defect of iodide organification with a
ô
( f
+
NORMAL
GOITROUS HYPOTHYROIDISM 
DECEASED
Fiaur© 49 s Famly history s caso 1 (CkB.) is sibling
case 2 is sibling 4 and case 3 is
sibling 5*
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discharge of doso from the gland* Although the patient was
euthyroid 6 weeks off therapy, he informed us that he was contemplating 
emigration• Because of uncertainty about his remaining in the 
Glasgow area, thyroxine therapy was recommenced#
OlHEK OF TUB FAMIIiY
The family tree is shown in Figure 49# There is no evidence of 
consanguinity# The parents had no clinical evidence of thyroid disease 
nor do other sibs# There is no history of deafness in any members of 
the family and there is no previous history of thyroid disease in other 
relatives #
DISCUSSION
These tlires brothers appear to have a dyshormoiiogenetic goitre 
due entirely or in part to defective organification of iodide within 
the thyroid. It is of particular interest that conventional 
perchlorate tests failed to reveal the defect vhiile the intravenous 
perchlorate test clearly demonstrated the abnormality*
Since the brothers had a similar biochemical defect, it is 
difficult to understand v/liy they showed such variation in clinical 
response to cessation of tliyroxine therapy* While it is easy to 
understand in case 2 why discontinuing thyroxine resulted in the rapid 
restoration of hypothyroidism, the outcome in case 1 could not have 
been predicted* He had been clinically and biochemically hypothyroid 
when first seen and had shown an excellent clinical response to 
thyroxine treatment* Stopping this treatment did not cause a relapse 
of hypothyroidism over a 3 year period despite continuance of the 
biochemical defect* Indeed his plasma TSH level at 28 months off
12:
thyroxine was in the normal range suggesting strongly that his thyroid 
was not under TSH stimulation which would have been expected if even 
mild hypothyroidism had been present (Evored et al, 1973)* When 
hypothyroidism eventually re«appeared after 3 years the biochemical 
defect became more obvious on testing and his plasma TSH rose.
Although no similar reports have appeared in the literature,
Siondek et al (I96O) have documented a comparable phenomenon# These 
workers administered large doses of tliyroid hormones in the short term 
(a form of treatment referred to as Stoss therapy) to three liypothyroid 
siblings, each with a defect of thyroidal iodide organification and 
produced a protracted clinical remission of hypothyroidism for 6 months 
in 2 and 3j years in the third. In contrast to our own findings, 
however, they were unable to produce the remission with standard 
thyroxine replacement therapy# Zondek*s postulate that Stoss therapy 
possibly activated dormant enzymatic patlw/ays in the thyroid was 
criticised by Stanbury (I96I) on the basis firstly that it was 
impossible to exclude such factors as the surreptitious administration 
of thyroxine and secondly, that Zondek had failed to exclude a 
dehalogenase defect which would have responded to the iodide given in 
*Stoss therapy*# We are satisfied that in our patients, there was no 
surreptitious intalce of thyroxine and in case 1, the persistent 
moderately elevated radioactive iodine clearance of the thyroid would 
be against any self«medication. In addition we have shown that the 
HIT test was normal in case 1. It could also be argued that in 1963, 
the cause of hypothyroidism was the presence of severe iodine deficiency
" 130 -
in conjunction with a sub-clinical defect of thyroidal iodide 
organification» This appears unlikely since Glasgow is not an iodine 
deficient area and our patients® diets have not apparently varied over 
the last 7 years.
Although it can be shown that the defect of iodide organification 
in thyroid can vary in severity among affected patients with the 
disorder (Bax and Weiner, 196?)* it is difficult to understand why, 
in a single patient (case 1), the expression of the defect should vary 
from time to time. One must postulate that something occurred during 
thyroxine treatment to increase the efficiency of endogenous thyroxine 
formation and secretion but whether this was in response to the 
physiological replacement of thyroxine or whether it indicates a real 
spontaneous variation in the disease is a matter for conjecture.
" 131
SUHMRY * CHAPTER 13
Three male siblings with familial goitrous hypothyroidism due 
to a defect of thyroidal iodide organification have been studied* 
Withdrawal of thyroxine therapy from two of the brothers led to a 
rapid return of clinical hypothyroidism in one but the other brother 
remained euthyroid for approximately 3 years off his thyroxine therapy 
despite continuing evidence of defective iodide organification in his 
tl'yroid* The phenomenon is contrasted with that produced by massive 
administration of thyroid hormones (Stoss therapy), but no satisfactory 
explanation for its occurrence can be given#
- 132 "
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CHAPTER 16 
SUMMARY AND CONCLUSIONS
In recent years, it has become increasingly apparent that the 
in vitro measurement of plasma hormones concerned in thyroid homeo­
stasis provides an ideal basis for the clinical determination of 
thyroid status. Although the well Imown in vivo tests of thyroid 
function using radioactive iodine have thereby been relegated to a 
role of secondary importance, the widespread introduction of 
sophisticated imaging devices has generated renewed interest in the 
in vivo approach to thyroid investigation. Rapid changes in 
thyroidal radioactivity may be accurately analysed with ease using 
this equipment and the resulting information on the kinetic 
behaviour of tiiyroid radionuclides can provide unique information 
on different aspects of thyroid function.
In view of the potential importance of ttoroid kinetic studies 
in the understanding, investigation and treatment of human disease, 
the author’s objectives in this thesis were threefold. Firstly, 
since a scintillation camera was not available, to develop a 
directional counting system which could provide comparable 
quantitative data on rapidly changing thyroid radioactivity. With 
this system, and accepting contemporary precepts on thyroidal iodide 
kinetics, the second aim was to study the thyroid physiology of 
pertecimetate-^^*^Tc (^^\c) in health and disease ostensibly to 
define its precise role in thyroid investigation but also to explore areas
134
of therapeutic potential. Thirdly, to develop a sensitive index 
of iodide organification in thyroid which could be applied to 
investigate thyroid utilisation of iodide in normal subjects and in 
various congenital and acquired human thyroid diseases.
The directional counting system for continuous recording of 
tlQrroid radioactivity consisted of a closely collimated scintillation 
detector connected by scaler and ratemeter to an automatic recorder. 
The collimator, by design, Gonsiderab]y reduced the contribution of 
extrathyroidal radioactivity to total neck radioactivity thereby 
allowing more precise measurement of tliyroid radioactivity.
A significant arterio-venous difference in plasma ^^^^c and 
131
iodide-131 C l )  concentration, noted at early intervals following 
their intravenous injection, was recognised to be a major systematic 
error of early phase kinetic studies of thyroid and an approximation 
to minimise this was adopted.
99Following an account of autoradiographic studies with To in 
rat thyroid which confirmed the relevance of contemporary model theory 
to kinetics of pertechnetate in the thyroid, the thesis continued 
with studies to define the role of ^^ "^ Tc in clinical investigation 
and treatment of human thyroid disease* Using the adapted 
directional counting system, quantitation of thyroid transport of 
^^*\c and in euthyroid and thyrotoxic subjects revealed direct
and equal proportionality between thyroid unidirectional clearance 
(U.D.C,) of and both unidirectional and net clearance of
This result indicated that, although time consuming, measurement of
the thyroid U.D.C, of gave a precise index of iodide transport
in thyroid unaffected by disorders of iodide organification. Thyroid
uptake of ^^®Tc, a simple alternative index of iodide transport, was
found ideal for routine clinical studies and valuable for diagnosis
of thyrotoxicosis* Since variation in the tliyroid exit-rate constant
(K^p) between patients could occasionally produce inaccurate values,
it was concluded that this measurement was most suitable for
sequential assessment of iodide transport in the same patient during
some therapeutic manoeuvre.
Pursuing thyroid pîiysiology, evidence was provided that the
thyroid exit rate-constant (K^p) was a result of simple ionic
diffusion from functional follicles. The close correlation between
exit rate-constants of ^^^c and ^^^1, both before (K^p), and after
perchlorate (K*^p), further indicated a similar if not identical
diffusion pathway from thyroid for each radionuclide. In addition
to a blocking action on thyroid transport of and ^^^I,
perchlorate magnified this diffusion by a factor of 2 to 3*
The thesis continued with an account of one possiblo application
for ^^^Tc uptalce measurements in human therapeutics, namely sequential
assessment of thyroid function after radioactive iodine therapy to
125
predict the adequacy of such treatment* Therapy with I was 
clearly shown to affect thyroid iodide transport in a biphasic manner 
with an immediate reversible effect, possibly dose-rate related, and 
a delayed irreversible effect, possibly proportional to the total 
deposited radioactivity. As a result, the thyroid uptaice of ^^“\cc
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125had most prognostic value 4 - 6 months after I treatment,
131Similar conclusions broadly applied to 1 therapy although this 
was not studied in comparable detail.
Following a change of theme, the thesis expanded the concepts 
of iodide organification in thyroid in relation to radioactive 
iodide kinetics and continued by describing in detail a new technique 
for detecting unorganified (inorganic) thyroidal I," This 
intravenous perchlorate discharge test, developed with particular 
reference to kinetic behaviour of inorganic iodide in thyroid, was 
shown to be simple and efficient. Inorganic iodide was not detected 
in euthyroid or thyrotoxic human subjects though moderate amounts 
were found in normal rat tlyroid. These findings indicated a basic 
difference in thyroid iodide metabolism between the species and 
argued that whereas iodide transport was rate-limiting for tliyroxine 
synthesis in humans, iodide organification was rate-limiting in 
normal rats.
To further define the utilisation of trapped iodide by human 
thyroid in vivo, the organification rate (Kg^ )^ of ^^^I was calculated 
in patients with organification disorders by means of a theoretical 
analysis developed with the aid of analogue computationè Although 
variation in inorganic iodide content of thyroid between patients 
rendered the i^ idex valueless for routine clinical use, its
sequential measurement in the same patient following radioactive 
iodine therapy illustrated the faulty utilisation of trapped iodide 
which may be present for a variable time after treatment*
1 ■■7
Application of the intravenous perchlorate test to the 
differential diagnosis of non-toxic goitre revealed inorganic 
in the thyroid of all patients with Hashimoto’s disease but also 
in about half those with simple goitre. It was concluded that the 
test was a useful adjunct to diagnosis in those euthyroid patients 
with low titres of serum anti-thyroid antibodies. The author was 
unable to evaluate the relative importance and contribution of 
defective iodide organification to the pathogenesis of simple goitre.
The thesis continued with a study to define the radiobiological 
effect of treatment with radioactive iodine-131 and 125 on iodide
organification in thyroid. Faulty utilisation of trapped iodide
125 131followed I more commonly than 1 therapy and this difference
between radionuclides was totally consistent with prevailing views
on their microdosimetry in thyroid.
The section ends with the account of an unexplained remission 
of hypothyroidism in one of three brothers each of whom had a defect 
of iodide organification in tliyroid.
This thesis has drawn heavily on the store of tliyroid model 
theory developed over the last two decades from sniaJl animal studies. 
Although there are subtle differences in thyroid physiology between 
species, it is clear that these thyroid models are relevant to the 
human situation and assist our understanding of some complex 
biochemical events in thyroid hormone synthesis.
Kinetic studies of thyroidal iodide metabolism currently play 
a minor role in the routine investigation and treatment of thyroid
113
disorders but clearly, the information obtained from their use may 
be equally of value in a clinical or research context. By indicating 
the scope of such studies and establishing areas for future 
development, the author has underlined the clinical importance of 
these concepts of kinetic analysis which were only recently 
introduced into the study of human thyroid disease.
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TABLE A«KTAVk-ViAsua
RESULTS OF KHSTIO ANALYSIS FOR AND ^^^TC
USING TffiE TWO-OOMPARTMENT THYROID MODEL s
l/n5ASllR3«NT IN PATIENTS WITH A BLOCK TO 
THYROIDAL IODIDE ORGANIFICATION
GRAPHIGAL/PIGITAL MALYS IS
99nifp 15lj
PATIENT G L/min Ï4n-pjaia“^ 0 L/min Spp-JBÎSr,—'J .'r  '' ■
1 0.106 0.116 0.210 0.086
2 0.073 0.140 0.179 0.099
3 0.072 0.036 0.184 0.047
4 0.076 0.064 0.133 0.050
5 0.055 0.079 0.115 0.075
6 0.064 0.087 0.156 0*068
7 0.071 0.140 0.216 0.106
8 0.117 0.054 0.252 0.044
9 OUO95 0,125 0.155 0.052
10 0.095 0.097 0.125 0.053
11 0.096 0,046 0.278 0.054
12 0.051 O.O67 0.126 0.060
13 0.024 0.045 0,060 0.040
14 0.082 0.140 0.158 0.079
I h X
CORRELATION B E T « N  THYROIDAL EXIT-RATE CONSTANT
CORRELATION B E T « N  THYROIDAL EXIT-RATE CONSTANT
AFTER PERCHLORATE
99%To
PATIENT IC
1 0.260
2 0.105
5 0.094
4 0.080
5 0.053
6 0,140
7 0.150
8 0.100
9 0.140
10 0.290
11 0.060
12 0.125
15 0.093
14 0*008
15 0.125
16 0.090
r S3 0.64
JQP/o Confidence Limits
Gradient,1.77 and 0.87 (+ !
Intercept.0.32 and 0,20 (t
0.67
0.24
0.38
0.28
0.25
0.44
0.39
0.55
0.38
0.55
0*24
0.55
0,40
0*42
0*60
0*50
y = 1.32x -h 0,26
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TABLE C
CORRELATION BETWMDM THYROIDAL EXIT-RATE CONSTANT
131j
RCTJBg ic^r ° y Ki^ piïïâ£iLï-2;
1 0.088 0.20
2 0.110 0.20
3 0.045 0.15
4 0.039 0,12
5 0.075 0.14
6 0.070 0.16
7 0.050 0.20
8 0.050 0.18
r =, 0.52 y ^ 0.67X + 0.12
705^  Confidence LimitsMW—— — — —  — —  —
Gradient,1*16 and O.I72 (+ 74/0* 
Intercept*0.16 and 0*09 (± 27^).
143
TiVBLE ])
MEASUREMENT OP THYROIl) UNimiRECTIOKAL CLEARANCE 
OF correlation BETWEEN GRAPHICAL/
DIGITAL AND ANALOGUE ÈlJilTHODS OF ANALYSIS
ark^ irdCJ.jau ]t ftP.\a*vi.* w * a Jt^ '- *  &L&» rpw#:f«r^
UNIDIRECTIONAL CLEARANCE
PATIENT GRAPHICAL/DIGITAL (y)
1 0.240 0*265
2 0.347 0.188
3 0.114 0,075
4 0.071 0.066
5 0.022 0.017
6 0*076 0.063
7 0.147 0*097
8 0*104 0*065
9 0*072 0.060
10 0*220 0.220
r “ 0*86 y - O.yix 4 0.01
70?a Confidence Limits
Gradient .0.88 and 0.55 (± 23%&).
Intercept,0.055 and - 0.017 (± 270^).
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TABLE E
#ASÜ1M#'!T OF THYROID EXIT-RATE CONSTANT 
OF ^^^Tcg CORRELATION BETWEEN GRAPHICAL/ 
DIGITAL AND ANALOGUE METHODS OF ANALYSIS
^^ ”^ 0 EXIT-RATE CONSTANT
PATIENT GRAPHICAL/DIGITAL (y)
1 0,130 0.170
2 0,123 0.072
3 0,210 0*140
4 0.071 0.068
5 0,090 0.069
6 0*067 0*067
7 0*122 0*085
8 0*180 0.110
9 0*124 0*097
10 0*200 0*180
r a 0*80 y “ 0.69% 4- 0,12
"iCffo Confidence Limits
Gradient .0,89 and 0,496 ( ±  28^ o),
Intercept .0,041 and - 0,016 231/)),
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APPENDIX 2
STANDARD , METHODS
THYROIDPLASMA
OUT
FifjiLTG 50: Block diagram of analogue computox’ oirouxt for o,
•fcwo-Gompartmeni; tliyroicl model.
— oOUT
ORGANIFIED
CONTENT
-OOUT
TOTAL
CONTENT
OPs
---------- OOUT
UNORGANIFIED
CONTENT
PLASMA THYROID
F-i.S-ure 51s Block diagram of aimloguo computer circuit for a 
three-coBipartment thyroid model.
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STANDAPD I4BTH0D8
ANALOGUE OOmUTATION UDING Wm-CÜMPARTIŒNT MODEL
The block diagram of the circuit for a tv;o«compartment thyroid 
model is shown in Figure 50#
Assuming bi-oxpoiiential decay for plasma radioactivity 
or P- and are adjusted to the predicted plasma concentration
(fract. dose/1) at zero time, Suitable adjustment to the decay rate 
of the first and second exponential term are made using and 
until the output of the summing ampliflier corresponds to the measured 
decay curve of plasma radionuclide over 20 minutes. Time scale v/as 
1 min/second.
A fraction of output of S is selected by P^, representing thyroid 
unidirectional clearance, and transferred to the input of Integrator 
A^ with Pg set at zero. A fraction of output of A^ is subtracted by 
Py, representing nnd the resulting total output is equivalent to
thyroid content of radionuclide as a function of time. The values 
of and Py are adjusted until the best correspondence between model 
output and actual data on thyroid uptake is obtained. The values of 
(unidirectional clearance of tliyroid) and Py (N^p of thyroid) may 
then be read from the potentiometers,
ANALOGUE COMPUTATION USING THREE-CONPARTMBNT MODEL 
The block diagram of the circuit for a three-#compartment model 
is shown in Figure 51# It comprises the basic two-compartments with
14?
an additional integrating amplifier as the third or organified 
1311 compartment.
131The plasma generator is adjusted to plasma curve of I as
before. A fraction of output of SI is selected by (unidirectional
clearance) and transferred to the input of integrator with set
at aero. l\;o fractions are subtracted from output of A^, which
131represents thyroid content of unorganified ‘ I. Firstly, the
fraction subtracted by Py representing diffusion via and secondly,
subtraction by Pg representing organification via This fraction
331of unorganified I which is organified is transferred to the output
of integrator A^* Output of this unit represents total organified 
131thyroidal 1 as a function of time. Outpuis available from the
*1 "ZT *1 *2*1
computer are organified I in tliyroid, unorganified I, and total 
thyroidal
Using several plasma decay curves for and various values
for unidirectional clearance, and curves of unorganified 
and organified thyroidal were recorded for each group of settings• 
PREPARATION OF SODIUM PERCHLOPATE 
The sodium perchlorate was dissolved in sterile distilled water 
and filtered through a sintered glass pipeline filter. After placing
in ampoules, it was autoclaved at 115° for 40 minutes* The solution
was quality controlled by passing tiirough an ion-exchange resin 
(Amberlite IE 120H), eluted with de-ionized water, and the eluate 
titrated with 0.1 M-NaOH.
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MIOTMTIOAL DERIVATIONS
PERCHLORATE
*
cô
'o
I
T3
2
g 20
Mins.
Figure 52î Perchlorate discharge simulation. is the inorganic
thyroidal I at 10 minutes after IV injection of radio*
151nuclide and the organic thyroidal I at this time.
151is the inorganic thyroidal I which is discharged 
from the gland after IV perchlorate administration at 10 
minutes.
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APPENDIX 3
miHEMATIOAL DERIVATIONS
Perchlorate Discharge Simulation
Ag shovm diagrammatically in Figure 52,
1 ~A1
Let = unorganified thyroidal I at 10 mjjiutes
1"5*I
= organified thyroidal I  at 10 minutes
131= unorganifiod thyroidal I discharged by perchlorate
131K*^p - perchlorate induced thyroidal exit-rate constant for I
131” thyroidal organification rate constant for I 
From the basic tliree-compartment model (Chapter 4) and making no 
assumptions about iodide organification during the perchlorate discharge 
which commences at 10 minutes, 
dT/dt = - T (K'yp ly)
T(t) = Tg,e **’ where t = time after perchlorate.
Mow dB/dt =
P
B(t) = / I(t)
f t
B(t) = l y  y
/ o
B(t) = Bg -
KVjp'i'
B(t) == B - S^?B .T . ) e j
K'mo L JTP TB
This expression B(t) indicates the amount of organified thyroidal
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131I at time *t* after perchlorate.
Nov; sum the organified B(t) and unorganified T(t) thyroidal 
pools.
B(t) + T(t) = T .G + B " .T . le -1
%'TP + K%g l_
T .e "(K^TP - S b .T .e + ^TB'^o
K»^p -I- K*^p +
+ o
T .e "(^ ''TP ■* o
K.pjj
K * 4, K
TP  ^ TB J
K .T + \ ’B o •{■
K'iP S b
At infinity, when t £=c>0 , e *  ^~ 0.
131 N .T
Therefore, total thyroidal I a t c O  “ + TB o
K*TP S^?B
Consequently, T,(cO) - T - ^TB*^o
%'TP +
T,(<>0) ^ T 1 « TB d o \
TP TB
T^(c/0) = 1 ~ S b
T K'TP* S^l’Bo
T feJO )
Therefore, if "%2r 0 after perchlorate administration, d will
^o
equal 1 since T^ C^^ sO) = T^,
Now, to obtain /\ T^(t), the amount of unorganified still to
discharge at »t*, we subtract the total thyroidal at c O  from the
131total thyroidal I uptalce at *t*.
151
]\ T^(t) " "CK'TP %TB
/\ T,(t) = T ,e "(K^TP S^?B
'* ^ I^'B 
4- \ b *^ o
^*TP S b
^*TP S s  .
Divide by T^ («s>0).
h s.(t)
tT S S T
r
1 -
K* -Î* K TP TB
A  %d(t)
KTB
^o- li
^^ ’tP '*” S^?B
Ki„„ -I-TP
A v " )
ï % % o T
= e
Therefore, the fractional rate of decrease of T during discharge 
equals the sum of K*^p and and
K'^r (observed) = (actual) -i- K^g.
I am grateful to Dr. R. Bessent for his assistance in the solution 
of this problem mathematically.
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123Calculation of Effective Half-Life of 1 Therapy in Thyroid
The mean biological half«life (T^ ) of in 12 patients = l6 days*
Physical half-life of = 60 days*
Since gjcj i»ij»u»j ^s»i5j<>|jaiii i i ■!» ■“  <w K\ i mw # ym #w #W * iw ™ pp m mwmwMm*,p * •  *«m m c=w «6W ' "«Alm nwr'M.iimWMnmU"Tji^ (effective; T<j (hiological) Tj (pt%rsical)
Mean Effective T-, = 12*6 days,
Let A(t) = fraction of therapy radioactivity in gland at time »t*
after 24 hours.
A(24) = fraction of therapy radioactivity in gland at 24 hours*
D(t) = total radiation dose deposited in gland at time *t'.
123
mean effective half-life of I in gland.
Then dD/dt si A(t) at time *t*.
0.693'g
Since A(t) o< A(24)*e
dD/dt csH^ A ( 24 ) • e
0.693t
D(t) o< A(24) / ©
o
! î à  •
0.693t
"4
0.693t ,
1 » e
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